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General introduction 11
I. tHE Human CornEa
The cornea, conjunctiva, and intervening transition area known as the limbus comprise 
the tissue at the ocular surface. The cornea functions as a protective membrane and a 
“window” through which light rays pass to the retina.
In the ideal refractive state, emmetropia, an image is focused directly on the retina, 
resulting in the perception of a sharp image in a healthy visual system. In myopia (near-
sightedness), the image appears focused anterior to the retina, producing a sharp image 
at near and a blurred image at distance. The inverse is true in hypermetropia (farsighted-
ness), where the image is projected posterior to the retina, producing a blurred image 
at near and a sharper image at distance. Astigmatism (cylindrical error) is the result of 
two different refractive powers between two perpendicular meridians. As an object is 
brought nearer to the eye, focus is maintained by an increase in the power of lens of 
the eye; this is accommodation. The ability to accommodate decreases with age (pres-
byopia).
The human cornea is composed of five distinctive anatomical layers (Fig 1). From 
anterior to posterior these are: the epithelium with its basement membrane; the 
stroma, which is subdivided into Bowman’s layer, the lamellar stroma, and Descemet’s 
membrane; and the endothelium. Part of Descemet’s membrane is in fact the basement 
membrane of the endothelium, and, therefore it is sometimes considered to be part of 
the endothelium. The endothelium lines the posterior corneal surface and is derived 
from the neural crest during embryologic development.1 Human endothelial cell den-
sity is approximately 6000 cells per mm2 during the first month of life, but decreases to 
about 3500 cells per mm2 by the age of 5 years. Growth of the cornea accounts for some 
of this decrease in density, but a decrease in the number of cells also occurs.2 Central 
Fig 1. Corneal structure. (J Leenen)
(See also Colour Figures, p. 135.)
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endothelial cell density decreases throughout life at an average rate of about 0.6% per 
year, so that the mean cell density is found to decrease from 3400 cells per mm2 at the 
age of 15 to 2300 cells per mm2 at the age of 85.3 There is no evidence that human en-
dothelial cells divide under normal circumstances, although they can divide in cultured 
corneas.4 With the decrease of cell density, there is, to a certain extent, a corresponding 
increase in cell surface area to maintain the barrier properties of the endothelial mosaic.
II. CornEaL tranSPLantatIon
1. Indications of corneal transplantation
Improvement of vision is the usual indication for corneal transplantation. However, 
preservation of the globe, cosmetic appearance of the eye and reduction of pain due 
to corneal pathology are other indications. The indications for corneal transplantation 
vary along with geographic location and institute. The last three decades, the leading 
indications for keratoplasty were failed grafts, pseudophakic bullous keratopathy (PBK), 
Fuchs’ endothelial dystrophy (FED), keratoconus (KC) and corneal scars.5
PBK is a corneal disorder caused by endothelial decompensation secondary to trauma 
(for instance by surgery), glaucoma or congenital abnormalities. Clinically, the disorder 
results in corneal oedema and epithelial or subepithelial bullae. For the symptomatic 
stage of the condition, keratoplasty is the most effective therapy to relieve pain and 
restore visual acuity.
FED is a slowly progressive, bilateral primary disorder of the corneal endothelium. 
In the asymptomatic stage of the disease, slit-lamp examination discloses irregularly 
scattered excrescences in the posterior cornea, called guttata.6 Later, the patient’s visual 
acuity can decrease because of stromal oedema. The increasing number of corneal and 
intraocular surgeries performed (with the risk of an additional loss of endothelial cells) 
together with a longer life expectancy, elevate the risk for developing symptomatic 
FED.7 When a patient’s visual acuity deteriorates significantly, a keratoplasty is indicated.
KC is a non-inflammatory corneal ectasia, which usually starts at puberty and pro-
gresses until the third to fourth decade of life.8 The corneal ectasia results in a (myopic) 
irregular astigmatism, impairing the quality of vision. In the early stages, the refractive 
error can be corrected with glasses or contact lenses. In more advanced forms of KC or in 
case of contact lens intolerance, several surgical options are available to improve visual 
acuity. Ten to 20% of patients eventually require keratoplasty due to scarring in the visual 
axis, insufficient visual acuity with contact lens correction, or contact lens intolerance.9
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2. History and epidemiology of corneal transplantation
The first visual successful human penetrating corneal transplantation was performed by 
Eduard Zirm in 1906.10 Great advances in surgical instrumentation and techniques and 
the introduction of antibiotics and corticosteroids over the last century, significantly im-
proved the success rate of corneal transplantation. Corneal transplantation is one of the 
most widely practised form of clinical transplantation. In the Netherlands, 995 corneal 
transplantations were performed in 2009 and 1165 in 2010.11
3. recent developments in penetrating and lamellar keratoplasty
3.1. Penetrating keratoplasty
In traditional penetrating keratoplasty (PKP), the diseased cornea is replaced by full-
thickness corneal donor tissue. The full-thickness graft gives a superior visual outcome. 
However, regardless the fit of the donor and recipient cornea, this vertical wound type 
requires relatively tight sutures. Healing of a vertical corneal wound requires a minimum 
of 6 months and typically 1 year in adults. In a relatively high number of patients, stable 
vision is not achieved until many months after traditional PKP surgery. Mean postop-
erative astigmatism after PKP ranges from 2.5 to 3.5 diopters (D) or higher.12 13 Despite 
clear grafts, a significant number of patients have inadequate visual acuity because of 
a high or irregular postoperative astigmatism, often requiring selective suture removal 
or secondary procedures.14 Factors that may affect postoperative astigmatism include 
type and size of trephines15, time of suture removal or adjustment, apposition of donor 
and recipient tissues, and graft size.16 Larger graft size results in a higher degree of topo-
graphic regularity and a higher quality of vision. However, larger grafts involve a higher 
risk of graft rejection.17 18
The postoperative course of a PKP procedure can be complicated by suture-related 
problems. These can involve a cascade of events such as suture loosening, sterile infil-
trates, secondary infections, corneal ulceration, wound dehiscence with wound leakage 
and allograft rejection.19 Incomplete wound healing after PKP leads to a structurally 
weaker globe, and wound dehiscence occurs with a frequency of 0.6% to 5.8%. 20
To obtain a stronger corneal wound, many graft configurations have been proposed. 
In 1921, Carrel suggested a two-level, rectangular graft.21 The square graft was charac-
terized by a different size of the anterior and posterior layer of the graft. Afterwards, 
Franceschetti and Busin proposed this stepping wound configuration in a circular 
graft.22 23 They called it the mushroom graft. The principle of this keratoplasty type is a 
full-thickness central donor graft with a lamellar wound configuration in the periphery. 
The full-thickness graft provides a superior refractive and visual outcome in the center, 
the lamellar graft increases the surface area for stromal wound healing at the margins. 
A potential drawback of this type of grafting is that the procedure, compared with a 
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traditional PKP, is more time-consuming due to the difficulty of trephination. The avail-
ability of a femtosecond laser for trephination of the graft configuration might simplify 
the preparation of the corneal tissue.24 25 Corneal graft survival in the long term has been 
reported to range from 50% to 80% after ten years, with significant variation associ-
ated with indication for transplantation, socioeconomic and geographical factors.26  27 
Graft failure is defined as an irreversible loss of graft clarity. Risk factors for graft failure 
include post-graft uveitis or microbial keratitis, corneal vascularisation, recipient age 
and diagnosis, graft size, and occurrence of a rejection episode.28  29 Other important 
reasons for graft failure in PKP are (secondary) glaucoma, ocular surface problems, and 
late endothelial failure.30 31
3.1.1. Late endothelial failure
Late endothelial failure is gradual graft decompensation without apparent cause, 
unresponsive to corticosteroids, and without history of a rejection episode. It is the 
most common cause of late graft failure.32 After PKP, the graft loses endothelial cells at 
a faster than physiological rate, even in the absence of endothelial allograft rejection. 
Although especially marked in the short term, this abnormal cell loss persists, albeit at 
a much lower rate, for many years after transplantation.33 34 Armitage et al were the first 
to demonstrate that chronic endothelial cell loss after PKP can be approximated using a 
biexponential decay model.35
3.1.2. Graft rejection
The ability of the cornea to survive in the absence of systemic immune-suppression led 
to the proposition that the cornea is an immune privileged tissue at an immune privi-
leged site.36 The avascularity of the cornea is an important mechanism that attributes to 
this corneal immune privilege. Therefore, HLA-matching of donor tissue to the recipient 
status is usually not performed in low risk cases. Nevertheless, good graft survival rates 
are obtained.
The epithelial, stromal and endothelial layers of the cornea may each show its own 
characteristic rejection pattern. An epithelial rejection is seen as an elevated line, start-
ing in the periphery and progressing towards the center of the graft. The rejection reac-
tion of the stromal layer is characterized by subepithelial infiltrates, which are whitish 
infiltrates in the anterior stroma, randomly positioned in the graft.37 Like epithelium, 
the typical rejection of corneal endothelium is characterized by an advancing front 
of densely infiltrated and dying cells. This endothelium rejection line is known as a 
Khodadoust line.38 The endothelial rejection is the most common and has the worst 
prognosis since, once affected endothelial cells do not regenerate.
The immune privilege is not absolute and can be lost. Classic risk factors of corneal 
transplant rejection include previous corneal transplants, corneal neovascularisation 
Isabelle BW.indd   14 09-Sep-11   12:23:07 PM
General introduction 15
and inflammation.39 A loose or broken suture, associated with both inflammation and 
neovascularisation, has been identified as the leading associated risk factor for trans-
plant rejection after PKP.40 Reported rejection episodes after normal risk-PKP (patients 
with KC, FED, PBK) range from 7 % to 13 % within the first two years after surgery.41 42 
Fortunately, only a minority of the rejection episodes evolve to a failure of the graft. 
However, the survived graft has lost a substantial number of endothelial cells. Nguyen 
et al found that longer-term low-dose topical steroid treatment protects patients with 
normal-risk PKP against immunological graft rejections.43
3.2. Anterior lamellar keratoplasty
In anterior lamellar keratoplasty only the diseased epithelium, Bowman and anterior 
corneal stroma are removed and transplanted, leaving the unaffected Descemet and en-
dothelium of the patient in place. Indications for anterior lamellar keratoplasty include 
KC, epithelial and (anterior) stromal corneal dystrophies, and partial-thickness corneal 
scars.
In the 1970s, there was an increased interest in lamellar corneal transplantation.44 As 
a result of the technical difficulty of the procedure and the reduced postoperative visual 
acuity typically following lamellar keratoplasty, PKP remained the dominant corneal 
transplant procedure for the optical correction of corneal disease. A large part of these 
poor results were due to the irregular scattering of light at the recipient-donor wound 
interface. The need for a very smooth recipient and host surface at the wound interface, 
which was to be obtained more readily at a deeper corneal plane, was recognized early 
on.
Deep anterior lamellar keratoplasty (DALK) has several advantages over PKP surgery; 
no “open sky” related complications, no endothelial rejection, minor loss of endothelial 
cells, a better wound stability and less need for corticosteroids.45 Moreover, the time to 
suture removal and the time necessary to achieve stable results is considerably shorter.46 
There is no advantage to DALK for refractive error outcomes. Although improved graft 
survival in DALK has yet to be demonstrated, postoperative data indicate that DALK is 
superior to PKP for preservation of endothelial cell density. Endothelial graft rejection 
cannot occur after DALK, which may simplify long-term management of DALK eyes 
compared with PKP eyes.47
The main parameter for good visual function after anterior lamellar keratoplasty is 
the thickness of residual recipient stromal bed. An eye with a DALK with a residual bed 
of less than 20 μm has been shown to achieve a similar visual result as an eye with a 
PKP.48 49 In order to obtain a thin residual bed, various techniques have been used to ac-
complish baring of the Descemet’s membrane. These include intrastromal air injection,50 
hydrodelamination,51 viscoelastic dissection using an air-to-endothelium interface,52 
and blunt spatula delamination.53 However, the technique is difficult and Descemet’s 
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membrane perforation remains a major complication of DALK.54 If a large perforation of 
the Descemet’s membrane occurs, conversion to traditional PKP or a mushroom graft is 
necessary.
3.3. Posterior lamellar keratoplasty
The first human posterior lamellar keratoplasty (PLK) with a corneal limbal approach was 
performed by Charles Tillet in 1956.55 This technique was revised by Ko et al in 1993.56 In 
1998, Melles provided a breakthrough development when he demonstrated that donor 
tissue could self-adhere with the aid of an anterior chamber air bubble.57 Terry and 
Ousley subsequently modified this technique, renaming it deep lamellar endothelial 
keratoplasty (DLEK).58 This surgery required manual lamellar dissections within the deep 
corneal stroma of both recipient and the donor corneas. Despite excellent postoperative 
results, visual acuity after DLEK rarely exceeded 20/30 due to optical aberrations at the 
graft-host interface.59 60 To provide a smoother recipient interface, Melles et al introduced 
Descemet Stripping Endothelial Keratoplasty (DSEK).61 Instead of performing a lamellar 
dissection, the Descemet’s membrane was peeled off. This method accomplished two 
key objectives: it produced an easier procedure and it provided a possibly better optical 
interface. In Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), the do-
nor dissection is carried out using a mechanical microkeratome, which makes a smooth 
dissection deep within the corneal stroma.62
In the last few years, DSAEK has replaced PKP as the golden standard surgical treatment 
for corneal endothelial diseases. Its main advantage includes the lack of sutures, result-
ing in less induced astigmatism and a faster visual recovery. Furthermore, it is a safer 
technique with less risk of expulsive hemorrhage and suture-related complications.63 
The most common complications after DSAEK include posterior graft dislocations, 
primary graft failure, iatrogenic glaucoma, and endothelial graft rejection.64 Studies 
suggested that corneal transplant rejection is less frequent and less severe after DSAEK 
than after PKP.41 However, it is not clear yet whether these differences reflect an inherent 
reduction in the susceptibility to corneal transplant rejection in DSAEK or whether these 
are a product of extended postoperative topical steroid use. Moreover, some of these 
studies had a selection bias towards FED cases in the DSAEK-group. Compared to PBK, 
FED has a better transplant outcome.
The main concern for the DSAEK technique remains the rate of postoperative endo-
thelial cell loss, reported in various series to be in the range of 25% to 50% at six to 12 
months postoperatively.65-67 Recently, Price et al68 showed that overall graft success was 
comparable for the DSAEK and PKP procedure. However, the endothelial cell loss was 
higher with DSAEK at 6 and 12 months postoperatively, consistent with the endothelial 
trauma due to more donor tissue manipulation. Factors associated with lower endothe-
lial cell loss are single-point fixation forceps, absence of secondary donor reattachment 
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procedure and larger incision width (5.0 mm versus 3.2 mm).69 70 Folding of the corneal 
tissue during DSAEK causes more endothelial damage than glide insertion.71 The post-
operative decline of endothelial cell density is not significantly correlated with storage 
time or donor age.72
In Descemet Membrane Endothelial Keratoplasty (DMEK) the thickness of the trans-
planted layer of stroma is further reduced. Different techniques were developed by 
Melles, Price, and Kruse.73 74 75 The donor material consisting of endothelium, Descemet 
and a very thin layer of posterior stroma, spontaneously forms a roll, with the endothe-
lium on the outside. The donor roll can be introduced into the recipient eye using an 
inserter. After manipulation of this roll the donor disc is made to adhere to the recipient 
posterior stromal surface using an air bubble – as in DSAEK. The advantage of DMEK is 
an even quicker and improved visual rehabilitation than after DSAEK. However, donor 
preparation, positioning, and attachment are more challenging with DMEK, resulting 
in more donor tissue loss and a higher re-graft rate than typically experienced with 
DSAEK.75
III. IntraCornEaL ImPLantS anD CroSS-LInkInG
1. Intracorneal ring segments
Intracorneal ring segments (ICRS) are made of polymethyl methacrylate (PMMA) and 
are implanted in the deep corneal stroma to modify the corneal curvature. The tunnel 
is created at 80% of the corneal thickness and can be made by mechanical dissection 
using a manual semicircular dissector or by photodisruption of lamellar tissue using the 
femtosecond laser technology. Two types of ICRS are available: Intacs (Addition Technol-
ogy Inc, Des Plaines, Illinois) and Ferrara (Mediphacos, Belo Horizonte, Brazil) rings. The 
differences between these ring segments are a triangular cross-section and a smaller 
internal diameter of the Ferrara ring compared to the hexagonal cross-section of the 
Intacs.76 The corrective result varies in direct proportion to the thickness of the ICRS and 
in inverse proportion to their diameter.
The ICRS are initially designed to correct low myopia in normal eyes. The last decade, 
ICRS have been shown effective in reducing corneal steepening and refractive errors in 
KC,77 pellucid marginal degeneration,78 79 and post-LASIK ectasia.80 81 They might improve 
contact lens tolerance and prevent the need for keratoplasty in some of these patients.82
Patients with corneal ectasia are suitable for this treatment if they have clear central 
cornea, and a corneal thickness of 400 μm or more at the location where ICRS are to 
be placed. Reported results in patients with KC, show an increase in mean uncorrected 
visual acuity (UCVA) and best corrected visual acuity (BCVA) of two to four lines and a 
decrease in mean keratometry (K)-reading of 3 to 4 D.83 Alio et al reported that ICRS 
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insertion provides better results in visual acuity and corneal topography in eyes with 
mild to moderate KC (mean K-value ≤ 53 D) with a relatively low spherical equivalent 
(SE).84 There is only one study that suggests that patients with paracentral scarring or a 
cornea steeper than 57 D would benefit from ICRS insertion.85 Although most long-term 
follow-up studies show refractive and topographic stability, Alio et al reported a further 
significant increase in K-values 36 months after surgery.86 A summary of published stud-
ies on ICRS for KC, with a follow-up of 12 months or more, are listed in table 1.
Peroperative complications during ICRS implantation are rare; anterior and posterior 
corneal perforation has been described.87 The most common postoperative complica-
tion is ring segment extrusion or migration due to shallow placement.77 A common find-
ing after ICRS implantation is the presence of intrastromal deposits that accumulate in 
the lamellar channel after implantation. These channel deposits consist of intracellular 
lipids. However, they do not tend to grow and do not decrease visual performance.88
2. Intracorneal lenses
The use of corneal inlays to correct myopia or hyperopia involves creation of a lamellar 
flap and placement of synthetic material in the stroma. This modifies the optical power 
table 1. Outcomes of ICRS for keratoconus.
Study* Eyes Intacs/
Ferrara
FU Mean 
change 
SE (D)
Visual Acuity Change Mean change in keratometry 
(D)
Alió86 13 Intacs 48 mo 1.45 BCVA increased from 
o.46 to 0.66
Mean K decreased with 
3D. However, there was a 
significant increase in K-values 
between 36 and 48 mo
Colin107 100 Intacs 2 y 2.9 80.5% and 68.3% gained 
lines of UCVA and BCVA, 
respectively
Mean K decreased with 3.4D
Ertan108 118 Intacs 1 y 3.5 81.3% and 73.7% gained 
lines of UCVA and BCVA, 
respectively
Mean K decreased with 4D
Kwitko77 51 Ferrara 13 mo 1.45 86.4% gained lines of 
UCVA and BCVA
Mean K decreased with 5D.
Eyes with central KC had 
significant better results than 
eyes with inferior cones.
Kanellopoulos109 20 Intacs 12 mo 2.2 UCVA improved from 
20/154 to 20/28, BCVA 
improved from 20/37 to 
20/22
Mean K decreased with 3.2D
Torquetti 83 35 Ferrara 5y - UCVA and BCVA 
increased with 2 lines
Mean K decreased with 5 D
(BCVA = best corrected visual acuity; FU = follow-up; SE = spherical equivalent; UCVA = uncorrected visual 
acuity; mo = months; y = years; d = diopters. * First author only.)
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of the cornea by changing the shape of the anterior corneal surface. Another possibility 
to correct refractive errors is implantation of a lens with a higher index of refraction than 
the corneal stroma.
Synthetic stromal inlays or intracorneal inlay implants have been investigated for 
nearly half a century. In 1966, Barraquer proposed synthetic intrastromal implants to 
alter the anterior corneal curvature as a way to correct refractive errors.89 However, his 
results were unsatisfactory due to the impermeable nature of the implant lens material. 
Various types of synthetic inlays have been tested, including polysulfone,90 PMMA,91 
and hydrogel.92 The materials used in the first implants caused anterior stromal necrosis 
because they were impermeable to water and nutrients.93 New materials such as high 
water content hydrogel showed biocompatibility and good corneal tolerance when im-
planted in primates.94 Hydrogel lenses are permeable for water and nutrients, so normal 
corneal physiology can be maintained. Because of its refractive index (1.376), the lens 
has no refractive power of its own within the cornea. The refractive effect of the device 
is achieved through alteration of the corneal shape. Another advantage of intracorneal 
hydrogel lenses is that the technique is reversible. However, in the few decades these 
implants were superseded by laser refractive surgery and the implantation of phakic 
intraocular lenses. The intracorneal lenses fell into disuse.
Recently, interest in intracorneal implants has resurfaced, especially for the correction 
of presbyopia.95 96
3. Corneal cross-linking
In 2003, Wollensak et al developed a new technique for the treatment of progressive KC 
using corneal cross-linking (CXL) by ultraviolet A-light (UVA) and the photosensitizer ri-
boflavin. Recently, it has been introduced to reduce the progression in pellucid marginal 
degeneration and post-LASIK ectasia,97 and to treat patients with therapy-refractory 
infectious keratitis with corneal melt.98
The irradiation of the cornea is performed from a distance of 1 cm for 30 minutes, 
using a UV-A double diode, at 370 nm, and an irradiation of 3 mW/cm2. Before beginning 
UVA-irradiation, photosensitizer riboflavin in a 0,1% solution is applied to the cornea 
every 3 minutes for 30 minutes to achieve adequate penetration of the solution. The 
maximum effect of the treatment is in the anterior 300 μm of the cornea. As for the 
endothelium, a cytotoxic level for endothelium has been found to be 0.36 mW/cm2 
which would be reached in human corneas with a stromal thickness of less than 400 μm.
Reported results in KC show an average flattening effect of 2 to 3 D. Visual acuity 
improves slightly with one or two lines.99-101 In all of the treated eyes, the progression of 
KC was stopped. A preoperative maximum K-reading of more than 58 D is a significant 
risk factor for failure.102
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CXL treatment has a relative low complication rate. Described complications are cen-
tral stromal scars, bacterial keratitis,103 and Acanthamoebe keratitis.104 Diffuse lamellar 
keratitis has been reported after treatment in a case of post-LASIK ectasia.105 Age over 35 
years and a preoperative BCVA better than 20/25 are identified as significant risk factors 
for complications.102 Haze is a common finding after CXL and extends into the anterior 
stroma. The nature of this haze is unclear but it is associated with the depth of CXL and 
loss of keratocytes.106 Usually, the haze decreases during the first postoperative year.
objECtIvE anD outLInE oF tHIS tHESIS
The first part of this thesis aims to evaluate the clinical results of mushroom keratoplasty. 
Chapter 1 discusses the clinical outcome of the posterior mushroom (top-hat) kerato-
plasty in Fuchs’ endothelial dystrophy and pseudophakic bullous keratopathy. Chapter 
2 analyzes the visual and topographic results of mushroom keratoplasty in patients with 
advanced keratoconus.
The second object of this thesis is to discuss the technique of Descemet Stripping 
Automated Endothelial Keratoplasty (DSAEK). We evaluate the endothelial cell loss after 
both top-hat keratoplasty and DSAEK using a biexponential decay model (Chapter 3). 
Furthermore, we describe two complications of the DSAEK technique. Chapter 4 is a 
report on an endothelial rejection episode with the presence of a posterior Khodadoust 
line. Chapter 5 describes the introduction of epithelial cells, originating from the donor 
tissue, in the flap-graft interface.
The third part of this thesis discusses intracorneal implants and corneal cross-linking. 
Chapter 6 shows the usefulness of the combined treatment with Ferrara ICRS and CXL in 
patients with progressive KC to prevent the need for corneal grafting. Chapter 7 shows 
the long-term results of hydrogel intracorneal lenses in 2 aphakic eyes. The two patients 
were considered unsuitable candidates for intraocular lens implantation at the time.
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Posterior mushroom keratoplasty in patients with 
Fuchs’ endothelial dystrophy and pseudophakic 
bullous keratopathy; transplant outcome
Saelens IEY, Bartels MC, Rij Van G.
Cornea 2008; 27:673-8.
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abStraCt
Purpose: To report the outcome of posterior mushroom or top-hat shaped keratoplasty 
for patients with Fuchs’ endothelial dystrophy (FED) or pseudophakic bullous keratopa-
thy (PBK), concerning postoperative astigmatism, visual improvement, and endothelial 
cell density.
methods: Twenty-two eyes of 21 patients who received a posterior mushroom kera-
toplasty for FED (n = 19) or PBK (n = 3) between March 2003 and January 2006 at the 
Erasmus MC, Rotterdam, The Netherlands, were included. Visual acuity, refraction and 
keratometry were measured at 6, 12, 24, and 36 months. Specular microscopy was 
performed annually.
results: Best-corrected visual acuity (BCVA) significantly (p < 0.05) improved from 0.25 
preoperatively to 0.47 at 6 months and 0.65 at 1 year postoperatively. Visual acuity re-
mained stable with a BCVA of 0.62 2 years and 0.69 3 years after keratoplasty. At the last 
follow-up, the BCVA measured 0.5 or more in all but 2 (91%) eyes. Mean postoperative 
astigmatism at 1, 2 and 3 years measured 2.72 ± 1.48, 2.69 ± 1.85, and 1.75 ± 1.76 D. En-
dothelial cell density averaged 2143 ± 428 cells/mm2 at one year, 1539 ± 573 cells/mm2 
at two years, and 1920 ± 474 cells/mm2 at three years. All studied transplants remained 
functional and clear throughout the follow-up period.
Conclusion: The posterior mushroom keratoplasty in FED and PBK results in a relatively 
good visual acuity, a low astigmatism, and good endothelial cell density. The short-term 
results of our limited series of patients are encouraging.
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IntroDuCtIon
Fuchs’ endothelial dystrophy (FED) is a slowly progressive, bilateral corneal dystrophy, 
which is typically observed clinically in patients older than 50 years of age. Because of a 
progressive loss of endothelial cells, the endothelial function deteriorates, and corneal 
thickness increases while visual acuity declines.1-3 The increasing number of corneal 
and intraocular surgeries performed, together with a longer life expectancy, elevate 
the risk for developing symptomatic FED.4 When a patient’s visual acuity deteriorates 
significantly, a keratoplasty is indicated.
Pseudophakic bullous keratopathy (PBK) is a corneal disorder caused by endothelial 
decompensation secondary to trauma, glaucoma or congenital abnormalities. Clinically, 
the disorder results in corneal oedema and epithelial or subepithelial bullae. For the 
symptomatic stage of the condition, keratoplasty is the most effective therapy that can 
relieve pain and could restore visual acuity.5
PBK and FED are common indications for a penetrating keratoplasty (PK).6-8 Although 
PK can provide good clinical results for these disorders, postoperative visual recovery 
is often prolonged because of high or irregular astigmatism.9-11 Moreover, the preop-
erative corneal oedema in FED or PBK elevates risk of wound dehiscence after PK.12 The 
mushroom shaped wound configuration, first described by Franceschetti in 1951,13 
was reintroduced by Busin14 as “top-hat” keratoplasty using a manual approach. By 
fashioning a donor button with a shaped edge, a larger area of surface contact between 
the donor graft and the host was created. Advantages of this approach include a bet-
ter and faster wound healing. With a larger posterior diameter, a higher percentage 
of the diseased layer is replaced, possibly leading to a lower rate of slow endothelial 
decompensation after transplantation. Moreover, the self-sealing posterior lip provides 
a better wound stability during surgery. After 4 sutures have been placed, the anterior 
chamber is already formed. Consequently, the risk of a possible expulsive haemorrhage 
is reduced and further suturing can be done in a symmetric way, which might reduce 
the surgery-induced irregular astigmatism. Also, a posterior mushroom keratoplasty is 
easier to perform in phakic eyes than a posterior lamellar keratoplasty (PLK). Recently, 
an artificial anterior chamber has become available and can help in the accurate trephi-
nation of the mushroom configuration.
We studied the outcome of a posterior mushroom keratoplasty in patients with FED or 
PBK on visual acuity, astigmatism and endothelial density.
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matErIaL anD mEtHoDS
Patient and donor details
Between March 2003 and January 2006, a posterior mushroom keratoplasty was 
performed in 25 eyes of 24 patients for FED or PBK at the Erasmus MC, Rotterdam. The 
medical history of each patient was recorded preoperatively, and a complete eye exami-
nation was performed. All patients were scheduled for a PK because of insufficient visual 
acuity. Only primary transplants performed in FED or PBK patients with a follow-up of 
more than 6 months were included. Eyes with associated other corneal pathology were 
excluded. All of the procedures were performed by one of two corneal surgeons. The 
patient was, in consideration with the anaesthetist, free to choose between general and 
local anesthesia. Thirteen patients preferred general anesthesia and 9 patients under-
went surgery under local anesthesia.
The donor corneas were preserved in an organ culture medium without dextran up 
to three weeks. The donor tissue was evaluated for a second time and subsequently 
transported in a transport medium with dextran. All donor corneas were obtained from 
Bio Implant Service, Leiden, The Netherlands.
trephination and suturing techniques
The donor tissue was mounted on an artificial anterior chamber (Moria, Paris, France) 
after a viscoelastic substance (Healon®) was placed on the endothelium. The geometric 
center of the cornea was marked. A 7.5 mm Barron suction trephine was used to make a 
circular incision of 0.3 mm depth. A lamellar stromal dissection was carried out from the 
base of the incision to the limbus. The cornea was removed from the artificial anterior 
chamber and placed on a Barron suction punch (Katena) with the endothelial side up. 
A 9.0-mm donor button was punched out. The previous lamellar dissection allowed a 
superficial annular stromal lamella, 0.3 mm in thickness, which was removed in the area 
between 7.5 and 9.0 mm in diameter. (Fig 1)
The recipient bed was prepared to correspond with the shape of the donor button. 
The 7.5 mm Barron suction trephine, already used to the donor trephination, was used 
to cut a circular incision 0.3 mm in depth. The cornea was marked with a 9 mm trephine 
and a lamellar stromal dissection was carried out from the incision to the 9.0 mm mark. 
The anterior chamber was entered, and corneal scissors were used to complete the 
excision of the corneal button at the peripheral end of the posterior lamellar stromal 
dissection. (Fig 2)
An iridectomie was made at 12 o’clock. The donor button was positioned by sliding 
the peripheral wing under the 0.75 mm-wide superficial stromal lip of the recipient bed. 
The transplant was sutured with 8 interrupted sutures and 1 running 10-0 nylon suture, 
Isabelle BW.indd   34 09-Sep-11   12:23:08 PM
Posterior mushroom keratoplasty 35
or with 16 interrupted 10-0 nylon sutures. Additional procedures performed in combina-
tion with mushroom keratoplasty were noted.
At the end of the procedure, all patients received a subconjunctival injection of 1 ml 
of betamethasondinatriumphosphate (4 mg/ml) and 0.5 ml of gentamicin (40 mg/ml). 
A simple handheld keratoscope was used for qualitative keratometry.15 Sutures were 
a
c
e
b
d
f
Fig 1. The trephination technique of the donor cornea. (J Leenen)
A-B: The geometric centre of the donor cornea is marked and the Barron suction trephine (7.5 mm in 
diameter) is used to make a circular incision of 0.3 mm depth.
C-D: A lamellar stromal dissection was carried out from the base of the incision to the limbus.
E-F: The cornea was removed from the artificial anterior chamber and placed on a Barron suction punch 
(Katena) with the endothelial side up. A 9.0-mm donor button was punched out.
(See also Colour Figures, p. 136.)
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adjusted to correct astigmatism at the end of the procedure. Postoperatively, dexa-
methasone 0.1% eye drops were given 6 times a day for 2 months and subsequently 
tapered off during 1 year. Chloramphenicol 0.4% eye drops were administered 3 times a 
day for 2 weeks. Selective suture removal was performed postoperatively.
a
b
c
Fig 2. The trephination technique of the recipient cornea. (J Leenen)
A: The geometric centre of the recipient cornea is marked and the Barron suction trephine (7.5 mm in 
diameter) is used to make a circular incision of 0.3 mm depth.
B: The cornea was marked with a 9 mm trephine and a lamellar stromal dissection was carried out from 
the incision to the 9.0 mm mark.
C: The anterior chamber was entered, and corneal scissors were used to complete the excision of the 
corneal button at the peripheral end of the posterior lamellar stromal dissection.
(See also Colour Figures, p. 137.)
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main outcome measures and statistical methods
Main outcome measures included: visual acuity, astigmatism (Javal keratometer, Haag 
Streit, Bern, Switzerland), and endothelial cell density (cells/mm2, non-contact Topcon 
SP 2000P specular microscope). Visual acuity was defined as best-corrected visual acuity 
measured by the Snellen visual acuity chart. Total surgically induced refractive change in 
astigmatism was calculated with the use of vector analysis using keratometric results.16 
Preoperative and postoperative comparisons were made using the paired-sample t-test, 
and statistical significance was set at p = 0.05. The Kaplan-Meier plot was used to calcu-
late the average time until all sutures were removed.
rESuLtS
Donor details
The mean age of the donors was 69.5 ± 11.1 years and the average endothelial cell count 
of the grafts measured 2653 ± 257 cells per mm2.
Patient population
Two patients died within 6 months after surgery. A third patient developed a corneal 
ulcer, caused by a fungal infection with Exophiala, and a second graft was needed. All 
together, we studied 22 eyes of 21 patients with FED (n = 19) or PBK (n = 3). Patient age 
averaged 70.9 ± 10.3 years, and mean follow-up in this study was 2.3 ± 0.9 years.
keratometry
Mean preoperative astigmatism measured 1.23 ± 0.94 D. After keratoplasty, the mean 
absolute keratometric astigmatism was 2.76 ± 1.98 D at 6 months (n = 21), 2.72 ± 
1.48 D at 12 months (n = 22), 2.69 ± 1.85 at 2 years (n = 15), and 1.75 ± 1.76 at 3 years 
postoperatively (n = 8). Both vector analysis and t-test, showed no significant change in 
surgery-induced astigmatism during postoperative follow-up. Mean preoperative and 
postoperative corneal power is shown in table 1.
visual acuity
The preoperative BCVA was 0.25 ± 0.15. Postoperatively, the BCVA improved signifi-
cantly (p < 0.05) to 0.47 ± 0.20 and 0.65 ± 0.20 at 6 months (n = 20) and 12 months (n 
= 21) respectively. During follow-up, visual acuity remained stable (p = 0.57) with an 
average BCVA of 0.62 ± 0.24 at two years (n = 17) and 0.69 ± 0.25 at three years (n = 8, 
Fig. 3). At the last follow-up, all but 2 patients had achieved a BCVA of 0.5 or more. The 
low visual acuity in the 2 patients (0.3) was both due to age-related macular disease. 
Without considering these 2 patients, mean BCVA measured 0.69 ± 0.20 at one year, 0.69 
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± 0.18 at two years, and 0.74 ± 0.15 at three years postoperatively. Compared to the FED 
patients, lower visual acuity both preoperatively and postoperatively was seen in the 
patients with PBK. Due to the low number of patients with PBK, these findings could not 
be confirmed statistically.
Endothelial cell loss
Although there was a statistically significant decline (p = 0.0001) in average endothelial 
cell count during the first year after surgery (2143 ± 428, n = 17), endothelial cell count 
remained stable (p > 0.05) during further follow-up, with 1539 ± 573 cells per mm2 (n = 
8) at two and 1920 ± 474 (n = 7) at three years after surgery.
table 1. Pre- and postoperative patient data.
Variable Preoperative
(n = 22)
Postoperative
6 Mo
(n = 20)
12 Mo
(n = 20)
24 Mo
(n = 17)
36 Mo
(n = 8)
Mean age of donor ± SD (Y) 69.5 ± 11.1 - - - -
Mean endothelial cell count 
(cells/mm2)
2653 ± 257 - 2143 ± 428 1539 ± 573 1920 ± 474
Mean BCVA ± SD (range) 0.25 ± 0.15
(0.02 – 0.5)
0.47 ± 0.20
(0.2 – 0.8)
0.65 ± 0.20
(0.2 – 1.0)
0.62 ± 0.24
(0.1 – 1.0)
0.69 ± 0.25
(0.3 – 1.0)
Mean keratometric 
astigmatism (D)
1.23 ± 0.94 2.76 ± 1.98 2.72 ± 1.48 2.69 ± 1.85 1.75 ± 1.76
Mean flat/steep K-reading (D) 43.17/44.25 41.18/43.94 41.20/43.92 41.51/44.20 42.56/44.31
Mean keratometry (D) 43.79 ± 42 42.56 ± 3.0 42.56 ± 3.01 42.86 ± 2.85 43.4 ± 2.73
(BCVA, best corrected visual acuity; SD standard deviation; D: diopters; Y: years)
0,69
0,620,65
0,25
0,47
0
0,2
0,4
0,6
0,8
1
0 0,5 1 1,5 2 2,5 3
Follow-up (years)
B
C
V
A
 (S
ne
lle
n)
Fig 3. Pre-and postoperatively BCVA. (N = 22)
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Suture adjustment and suture related problems
Our policy is to remove all sutures 2 to 3 years postoperatively. In case of astigmatism, 
the suture at the steep axis was removed. A loosen or broken suture was removed im-
mediately. In 6 eyes, we recorded loosened sutures and in one eye cheese wiring. In one 
patient, we placed an extra suture 6 months postoperatively to correct high astigmatism 
(7.5 D). At the end of the study, all sutures were removed in 6 eyes (on average at 1.48 
years postoperatively). (Fig. 4)
Fig 4. Cumulative percentage of patients with all sutures out.
Peroperative and postoperative complications
In all but one eye, the surgical procedure was uneventful. The patient of this one eye 
woke up during surgery, and a choroidal haemorrhage with vitreous prolaps occurred. 
An anterior vitrectomy was performed and the intraocular lens had to be removed. The 
trephination of the first three corneal grafts was a little more eccentric than the others. 
Epithelialization occurred within 2 weeks after the procedure. All included keratoplasties 
remained functional and clear until last follow-up.
DISCuSSIon
In our study, patients with FED or PBK obtained satisfying visual acuity after posterior 
mushroom keratoplasty, which remained stable up to 3 years after surgery. All grafts 
remained clear and functional.
In most cases of FED and PBK, a keratoplasty is the only effective therapy for the symp-
tomatic stage of the condition. Graft survival for FED is good, with a long-term graft 
survival rate of 89%.9,17 Although the short-term graft survival rate in PBK is good (74% 
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at 5 years18), visual improvement is often poor.5 One of the major limitations of visual 
rehabilitation after PK is a high or irregular postoperative astigmatism, often requiring 
selective suture removal or secondary procedures. A faster visual rehabilitation may be 
expected after a PLK, where only the diseased endothelium is replaced.19,20 However, the 
presence of a lamellar interface may reduce the quality of vision after PLK compared 
with that obtained after PK.21 Moreover, a PLK is inadvisable in phakic eyes because of 
the working space that is needed.22-24
To improve the postoperative outcome of PK, several modifications of the wound edge 
have been described.25-28 In 2003, Busin described the posterior mushroom or “top - hat” 
keratoplasty.14 The principal of this keratoplasty type is a full-thickness central donor 
graft with a lamellar wound configuration in the periphery. The full-thickness graft gives 
a superior refractive and visual outcome in the center; the lamellar graft increases the 
surface area for stromal wound healing at the margins. This self-sealing wound configu-
ration could have major advantages. First, less tight sutures are needed, which might 
reduce suture-induced astigmatism. In our group of patients, selective suture removal 
was used. The postoperative astigmatism is relatively low and regular, with a mean 
keratometric astigmatism at all follow-up times of < 3 D. Our results are in line with 
the reported results after laser trephination of a mushroom keratoplasty.30,31 Second, the 
posterior peripheral wing of deep stroma and endothelium (0.75 cm in width) creates 
a horizontal surgical wound. The healing of this type of wound requires less time than 
the edge-to-edge wound in conventional PK, allowing earlier postoperative suture re-
moval and the risk of wound dehiscence might be reduced.14 31 We did not notice wound 
dehiscence in any eye during follow-up. Another advantage of posterior mushroom 
keratoplasty is that the self-sealing posterior lip provides a better wound stability during 
surgery. Because of the intraocular pressure that pushes the lamellar wing against the 
recipient cornea, the anterior chamber is formed after the first 4 sutures have been put 
in place. Further suturing can be done in a very symmetric way, which might decrease 
the surgery-induced irregular astigmatism.
A potential drawback of this type of grafting is that the procedure, compared with a 
conventional PK, is more time-consuming because of the difficulty of trephination. The 
availability of a programmable femtosecond laser might simplify the preparation of the 
corneal tissue and could create a more comparable wound configuration. Although the 
endothelial cell density 3 months after laser trephination was excellent, a longer follow-up 
and larger series are required to definitively demonstrate the potential advantage of laser 
trephination.32 Moreover, except for an artificial anterior chamber, no expensive instru-
mentation is required for the manual technique. The postoperative astigmatism and the 
visual acuity in our study are in line with recently published results of laser trephination.32
Visual acuity after keratoplasty is mainly a function of both retinal macular potential 
and the optical quality of the cornea. One year after the posterior mushroom kerato-
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plasty, 82% (18/22) of our patients gained a vision of 0.5 or better. In 2 of the 4 eyes with 
a BCVA less than 0.5 age-related macular disease was present. In the 2 other patients, 
the visual acuity improved with time. In line with previously reported studies,37 the post-
operative visual improvement in our patients with PBK was lower compared to patients 
with FED. Our relatively good postoperative visual acuity might be explained not only by 
the low amount of surgery-induced astigmatism, but also by the greater corneal surface 
regularity after the posterior mushroom keratoplasty. Compared with reported results 
on visual acuity after conventional PK in patients with FED or PBK (BCVA ≥ 0.5 in 64% of 
the patients)9, our results are more favourable.
Corneal endothelial cells do not divide in humans and there is a well-documented, 
gradual decline in endothelial cell density with increasing age. The loss of endothelial 
cells is greatly exacerbated after PK. The number of donor cells that survive the trans-
plant procedure depends on the adequacy of the donor preservation and the amount 
of trauma during surgery.34 The decline in endothelial cell density is especially marked 
in the short term, but persists at a reduced rate during many years after transplanta-
tion.35 Patients undergoing a posterior mushroom keratoplasty usually receive more 
donor endothelium (9.0 mm diameter) than patients with a conventional PK (7.5-8.5 
mm diameter). In our study, endothelial cell density remained relatively high after up to 
three years postoperatively, with an average endothelial cell density of more than 1500 
cells per mm2 at all follow-up periods. After a significant decrease the first year after 
surgery, the endothelial cell density in our study remained stable during further follow-
up, and compares favourably with conventional PK. The rise in endothelial cell density 
during the third year can be explained by the fact that the patients with endothelial cell 
measurements in the second year are not the same as those in the third year.
A longer follow-up period is needed to study the effect of the wound configuration on 
the endothelium density. Although more endothelial cells are transplanted, the smaller 
anterior graft surface (7.5 mm in diameter) maintains a safe distance from the corneo-
scleral limbus. Consequently, the development of postoperative corneal neovascularisa-
tion and associated risk of graft failure might be reduced.35 There was no rejection noted 
during our mean follow-up of 2.3 years, which compares favourably to other reports of 
PK in FED or PBK.9,36
This study provides a longer follow-up and a higher number of patients compared to 
other studies of posterior mushroom keratoplasty.14,30-32 With inclusion of only FED or 
PBK patients, we evaluated the technique in a very homogeneous group. In addition, 
all corneal transplantations were performed by only 2 surgeons. Our results support the 
value of posterior mushroom keratoplasty in patients with FED or PBK. However, the 
obtained positive results require confirmation in a larger study group with a follow-up 
period beyond 3 years.
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abStraCt
Purpose: To evaluate the technique of anterior mushroom keratoplasty for patients with 
advanced keratoconus, with respect to postoperative astigmatism, visual improvement 
and stability, and endothelial cell count.
Design: A retrospective observational study.
methods: Sixteen eyes of 15 patients with advanced KC received an anterior mushroom 
keratoplasty at the Erasmus Medical Center at Rotterdam between April 2003 and May 
2006. The donor cornea had a larger anterior stromal lamella (9.0 mm in diameter) and 
a smaller posterior part (7.0 mm in diameter). Visual acuity and keratometry were mea-
sured at 6, 12, 24, and 36 months. Specular microscopy was performed annually.
results: Best-corrected visual acuity (BCVA) improved significantly (p = 0.003), from 0.25 
± 0.20 preoperatively to 0.62 ± 0.22 at 6 months postoperatively. Visual acuity remained 
stable with a BCVA of 0.70 ± 0.20 from 1 year onward. At all follow-up periods, mean 
postoperative astigmatism remained < 3.5 D. Mean postoperative astigmatism at 1, 2 
and 3 years measured 2.67 ± 1.95 (n = 15), 2.54 ± 1.86 (n = 6), and 3.30 ± 2.12 D (n = 5). 
The average endothelial cell count at 1 and 2 years was 1755 ± 678 (n = 12) and 1573 
± 546 (n = 5), respectively. At the end of follow-up, all transplants remained functional 
and clear.
Conclusion: The mushroom-shaped graft can combine the benefits of a good visual 
acuity, a low astigmatism, and rapid postoperative healing. The short-term results of 
our limited series of patients are encouraging. Further research is necessary to draw 
stronger conclusions regarding the long-term effects.
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IntroDuCtIon
Keratoconus (KC) is a non-inflammatory corneal disorder characterized by localized 
conical protrusion and thinning of the corneal stroma. Depending on the diagnostic 
methods, the incidence varies between 4 and 230 per 100,000.1 The diagnosis is made 
on the basis of progressive myopic astigmatism identified by refraction, keratometry, 
or corneal topographic analysis.2 If treatment with spectacles or contact lenses is in-
sufficient, different treatment options are possible, such as intracorneal rings,3,4 a toric 
Artisan lens,5 lamellar keratoplasty or penetrating keratoplasty (PK).7,15 Ten to 20% of 
patients eventually require keratoplasty due to scarring in the visual axis, insufficient 
visual acuity (VA) with contact lens correction, or contact lens intolerance.6
KC is a common indication for corneal transplantations.7 Although PK in KC gener-
ally has a good prognosis, it can be complicated by a high or irregular astigmatism, 
resulting in a delayed or poor visual recovery.9,10 Many factors can affect postoperative 
astigmatism. Astigmatism decreases with increasing graft size.11 However, larger grafts 
are shown to be associated with a higher risk of rejection.12,13 PK in a cornea with a thin 
periphery, as seen in advanced KC, carries the risk of a high postoperative astigmatism. 
Besides postoperative astigmatism, graft decompensation caused by endothelial rejec-
tion is the cause of poor visual outcome in up to 9% of the KC eyes after transplantation.14
To avoid the risk of endothelial graft rejection, an anterior lamellar keratoplasty (ALK) 
can be performed. Advantages of ALK over PK surgery are the extra-ocular procedure, 
the preservation of recipient healthy endothelium, a better wound stability and less 
need for corticosteroids.8 Moreover, the time necessary to achieve stable results is 
considerably shorter.15 However, the presence of a lamellar tissue interface may reduce 
the quality of vision after ALK.16-18 Although optical results are shown to be better with 
microkeratome - assisted LK, this procedure can only be performed if a minimal corneal 
thickness of >380 μm is present. A recent study suggested that the main parameter 
for good visual function after ALK for KC is the thickness of residual recipient stromal 
bed. An eye with a deep anterior LK with a residual bed of < 20 μm has been shown to 
achieve a similar visual result as a PK.15 However, the technique is difficult, and Descemet 
perforation is a well-described complication of deep ALK.19
To combine the optical superiority of a large-diameter PK with some of the wound-
healing advantages of a LK, a mushroom shaped keratoplasty has been proposed.20-22 A 
central full-thickness donor graft with a lamellar wound configuration in the periphery 
is used. Recently, an artificial anterior chamber has become available and can help in the 
accurate trephination of the mushroom configuration. We studied the outcome of an-
terior mushroom keratoplasty in KC patients on visual acuity, refraction and endothelial 
cell density.
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PatIEntS anD mEtHoDS
Patients and donor details
Between 2003 and 2006, a mushroom keratoplasty was performed in 16 eyes of 15 pa-
tients for KC at the Erasmus MC, Rotterdam, The Netherlands. The medical history of each 
patient was recorded preoperatively, and a complete eye examination was performed. 
Seven patients had an allergic constitution. All patients were scheduled for PK because 
of insufficient VA or contact lens intolerance. Only primary transplants performed in 
KC patients with a follow-up of > 6 months were included. Eyes with associated other 
corneal pathology were excluded. All of the procedures were performed by one of two 
corneal surgeons.
The donor corneas were preserved in an organ culture medium without dextran at 
31°C up to 3 weeks. The donor tissue was evaluated a second time and subsequently 
transported in a transport medium with dextran. All donor corneas were obtained from 
Bio Implant Service, Leiden, The Netherlands.
Surgical technique
The donor cornea was mounted on an artificial anterior chamber (Moria, Paris, France) 
after a viscoelastic substance (Healon®) was placed on the endothelium. The geometric 
center of the cornea was carefully marked, and a 9.0 mm Barron suction trephine (Kat-
ena) was used to make a circular incision of 0.3 mm depth. The Barron trephine provides 
suction indentations that are inked centrally on the donor in the quadrants to provide 
guidance for the first 4 suture placements. A central circle of 7.0 mm was marked with 
a non-disposable trephine and inkpad. A lamellar stromal dissection was carried out 
from the circular incision up to the 7.0 mm mark. The artificial anterior chamber was 
entered with a 15° razor blade knife, and curved Vannas corneal scissors were used to 
complete the excision of the corneal button. The upper side of the Vannas scissors was 
held slightly inwards to prevent oblique wound edges. The donor button obtained 
consisted of a large anterior stromal lamella (9.0 mm in diameter) and a small posterior 
diameter (7.0 mm). (Fig 1)
If there was superficial vascularisation of the recipient cornea, a fornix-based con-
junctival flap was performed in these quadrants. The geometric center of the recipient 
cornea was carefully marked. The center of the pupil tends to be located slightly nasally. 
Whenever this was the case, we marked the cornea ~ 0.3 mm nasally from the center of 
the cornea to obtain a better centration of the graft with the pupil. The recipient bed 
was prepared to correspond with the shape of the donor button. The 9.0 mm Barron suc-
tion trephine, already used for the donor trephination, was used to cut a circular incision 
of 0.3 mm in depth. The indentations of the suction trephine were also inked. The central 
cornea was marked with a 6.5 mm trephine. A lamellar dissection to the central 6.5 mm 
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mark was carried out. (Fig 2) The excision of the corneal button was completed conform 
the method of the donor cornea. An iridectomy at 12 o’clock was made. Because this 
wound configuration is not self-sealing, the corneal graft was sutured in place. Eight 
single, superficial 10-0 Nylon sutures and 8 single, deep 10-0 Nylon sutures through 
the full thickness of the donor cornea and the peripheral lamellar wing were used to 
position the donor button.
At the end of the procedure, all patients received a subconjunctival injection of 1 
ml betamethasondinatriumphosphate (4 mg/ml) and 0.5 ml gentamicin (40 mg/ml). A 
simple handheld keratoscope was used for qualitative keratometry. If needed, sutures 
were adjusted to correct astigmatism at the end of the procedure. There were no other 
procedures performed in combination with the mushroom KP. Postoperatively, dexa-
methasone 0.1% eye drops were given 6 times a day for 2 months and subsequently 
tapered off during 1 year. Preservative-free chloramphenicol 0.4% eye drops were 
Fig 1. Trephination technique of donor cornea. 
(J Leenen)
A, The Barron suction trephine (9.0 mm in diameter) is 
used to make a circular incision of 0.3-mm depth.
B, A lamellar stromal dissection was carried out from 
the circular incision up to the 7.0-mm mark.
C, The donor cornea with a larger anterior stromal 
lamella (9.0 mm in diameter) and a smaller posterior 
part (7.0 mm in diameter)
(See also Colour Figures, p. 138.)
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administered 3 times a day during 2 weeks. Selective suture removal was performed 
postoperatively.
methods and main outcome measures and statistical methods
Main outcome measures included VA, astigmatism (Javal keratometer; Haag Streit, Bern, 
Switzerland), and endothelial cell density (cells/mm2; non-contact Topcon SP 2000P 
specular microscope). VA was defined as best-corrected VA (BCVA) measured by the 
Snellen chart.
To compare means, Student t-test was used. P < 0.05 was considered statistically 
significant.
a
b
c
Fig 2. Trephination technique of recipient cornea. (J Leenen)
A, The geometric center of the recipient cornea is marked. The Barron suction trephine (9.0 mm in 
diameter) is used to make a circular incision of 0.3-mm depth.
B, A lamellar stromal dissection was carried out from the circular incision up to the central 6.5-mm mark.
C, Vannas corneal scissors were used tocomplete the excision of the corneal button.
(See also Colour Figures, p. 139.)
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rESuLtS
Donor details
The mean age of the donors was 62 ± 10 years (range, 43-76 years), and the average 
endothelial cell count of the grafts measured 2757 ± 168 cells/mm2 (range, 2500-3100 
cells/mm2).
Patient data
From July 2003 to May 2006, there were 16 eyes of 15 patients with a diagnosis coded 
for both advanced KC and mushroom keratoplasty. One eye was excluded because a 
second graft was needed at day 6 due to a severe keratitis with hypopion. Mycobacte-
rium chelonae was cultured from the donor cornea and from the culture medium at the 
laboratory. All in all, we studied 15 eyes of 14 patients, with an average age of 36 ± 10 
years. Mean follow-up in this study was 24.47 ± 12.22 months.
keratometry and visual acuity
Of 15 eyes, preoperative refraction was obtainable only in 7 eyes because of high and 
irregular astigmatism. Mean preoperative keratometric astigmatism, measured with the 
Javal keratometer, was 5.45 ± 3.22 D (n = 13). Further preoperative values are summa-
rized in Table 1. After keratoplasty, mean keratometric astigmatism was 2.92 ± 1.27 D at 
6 months (n = 15), 2.67 ± 1.95 D at 12 months (n = 15), and 2.54 ± 1.86 at 2 years (n = 6) 
and 3.30 ± 2.12 at 3 years postoperatively (n = 5).
The BCVA preoperatively measured 0.25 ± 0.20, with a best spectacle-corrected VA of 
0.17 ± 0.16 (n = 8) and a best contact lens-corrected VA of 0.40 ± 0.19 (n = 5). Postop-
eratively, the BCVA improved significantly (p = 0.003) to 0.62 ± 0.22 and 0.70 ± 0.22 at 
6 months and 12 months, respectively. During follow-up, VA remained stable with an 
average BCVA of 0.72 ± 0.22 (p=0.70) at 2 years and 0.80 ± 0.14 at 3 years. During the 
last follow-up, all but 2 patients had achieved a BCVA of 0.6 or more. Four patients used 
contact lenses. The low visual acuity in one of the two patients (finger counting) was 
due to subretinal neovascularisation, associated with high myopia. The second patient 
table 1. Pre- and postoperative patient data.
Variable Preoperative Postoperative
6 Mo 12 Mo 24 Mo 36 Mo
Mean BCVA ± SD 0.25 ± 0.20 0.62 ± 0.22 0.70 ± 0.22 0.72 ± 0.22 0.80 ± 0.14
Mean keratometric astigmatism (D) 5.45 ± 3.22 2.92 ± 1.27 2.67 ± 1.95 2.54 ± 1.86 3.30 ± 2.12
Mean endothelial cell count (cells/
mm2)
2757 ± 168 1755 ± 678 1573 ± 546 950 ± 494
(BCVA: best-corrected visual acuity; SD: standard deviation; D: diopters)
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was known to have amblyopia in the operated eye. At the last recorded follow-up of 
all the patients, BCVA measured 0.72 ± 0.19. Without considering the 2 patients with 
extracorneal pathology, best spectacle-corrected VA measured 0.78 ± 0.12.
Corneal endothelial cell density
We measured an average endothelial cell count of 1755 ± 678 cells/mm2 at 1 year, 1573 
± 546 cells/mm2 at 2 years, and 950 ± 494 cells/mm2 at 3 years after mushroom kerato-
plasty.
Suture adjustment and suture related problems
Our policy is to remove all sutures 2-3 years postoperatively. In case of astigmatism, the 
suture at the steep axis was removed. A loose or broken suture was removed immedi-
ately. Seven patients had at least 1 loosened suture and 1 developed a sterile infiltrate. 
Additional sutures were placed in 3 patients.
Intra - and postoperative complications
All of the patients underwent surgery under general anesthesia. Surgery was uneventful 
in all patients. Epithelialization occurred within 2 weeks after the procedure. Postop-
eratively, 1 patient needed an extra suture because of wound leakage. Three years 
postoperatively, another patient developed an intraepithelial cyst of unknown origin 
that was removed. All keratoplasties remained functional and clear until last follow-up.
DISCuSSIon
In our study, patients with advanced KC obtained satisfying visual acuity after mushroom 
keratoplasty, which remained stable up to 3 years after surgery. All grafts remained clear.
Because only primary transplants for KC patients were included, we evaluated the 
technique in a homogeneous group of patients. In addition, all corneal transplantations 
were performed by the same 2 surgeons. To our knowledge, this is the first study to 
provide the results of the mushroom keratoplasty using the disposable Hessburg-Barron 
suction trephine and the artificial anterior chamber. A drawback of this study is the 
overall few included patients and the relatively restricted follow-up period. Because it is 
a retrospective study, patient data can be incomplete.
The mushroom keratoplasty is not a new technique. As far back as 1950, Franceschetti 
published results of the “greffe-champignon”.20,21 At that time, the indications for this 
procedure were unsatisfactory result of previous lamellar keratoplasty or PK, severe 
burns, trophic corneal disorders of aphakia, unfavourable cases with irregular cornea 
surface, staphylomas, descemetocele, and Fuchs’ endothelial dystrophy. Unfortunately, 
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his mechanical cutter for the donor graft was traumatizing for the corneal endothelium 
and difficult to use. Afterwards, Stocker tried to refine the trephination technique, but it 
resulted in imperfect matching between the graft and the recipient bed.23 Also, Roberts 
with the mechanical suction trephine, and Keates et al with the fixation clamp, tried to 
optimize the trephination of the donor cornea.24,25 Despite all efforts, accurate trephina-
tion was still difficult to perform. Because better surgical devices have recently become 
available, there is new interest in mushroom keratoplasty. The disposable Hessburg-
Barron suction trephine and the artificial anterior chamber facilitate a punctual trephi-
nation with minimal trauma to the endothelial layer.26
Transplantation of a larger anterior diameter, like the one in a mushroom keratoplasty, 
results in a higher degree of topographic regularity and a higher quality of vision.27 
Close proximity of the anterior layer to the limbus of the recipient may lead to suture 
loosening and wound healing problems. This is particularly true for allergic patients with 
vascularized corneas. To avoid this, we made a fornix-based conjunctival flap and placed 
sutures into the sclera in these quadrants. Although the diameter of this posterior graft 
was only 7 mm, there were no complaints about glare or halos. The elevated risk for 
graft failure, seen in larger graft diameters, is probably avoided because of the smaller 
posterior lamella in mushroom keratoplasty.28,29
The first 2 years after surgery, the endothelial cell density in our group of patients 
remained relatively good. However, endothelial cell loss after PK is an ongoing process 
even years after surgery.30-32 Our data showed a rise in endothelial cell loss 3 years after 
keratoplasty. Because we have data of only 30% (n = 5) of our patients in that follow-up 
period, more patient data are needed to draw stronger conclusions regarding the long-
term effects of manual mushroom trephination in KC patients.
Although the corneas of our patients were steep, with an average steep K-reading of 
60D and a thin periphery, our results are in line with the reported success rate (range, 
70% - 91%) of PK in general KC patients, defined as a VA of > 0.5 at 18 months postop-
eratively.33-36 Suturing a conventional full thickness penetrating corneal graft in patients 
with a zone of marked inferior corneal thinning is more prone to develop a higher post-
operative astigmatism and thus a lower BCVA because of wound healing problems (Fig 
3A). Because of the particular shape of the mushroom-shaped graft, the donor and the 
recipient are locked to each other. This way, the graft is unlikely to dislocate (Fig 3B).
In patients with a zone of marked inferior corneal thinning within 2 or 3 mm of the 
inferior corneal limbus, we used to perform a large (9.0-9.5 mm) lamellar graft first. Many 
of these patients had a central corneal scar. To obtain a good VA, a conventional full-
thickness PK of 8 mm was performed into the lamellar graft 1 year postoperatively. The 
mushroom keratoplasty requires only 1 procedure, and the results are much better than 
our results of conventional keratoplasty in patients with KC with marked inferior corneal 
thinning
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The reported graft rejection rates are relatively low in patients with KC, with a 5-year 
graft survival that varies around 97%.37,38 All of our grafts remained clear, and no rejec-
tion periods were noted.
During follow-up, we noted a minor increase in keratometric astigmatism. The ten-
dency towards a myopic shift is confirmed by published data of PK in KC patients.39 
This slight increase was not significant (p = 0.34), and the postoperative corrected 
VA remained stable. Despite the fact that most of the BCVAs were obtained by using 
spectacles (n = 11) instead of contact lenses (n = 4), our results concerning BCVA are 
comparable with previous reported results of PK and lamellar keratoplasty for KC.18,40
Although the prevalence of KC is generally reported to be identical in male and female 
patients, higher rates of PK have been reported in male subjects.42 In our study, 73% 
(11/15) of the patients were men.43
The mushroom technique does not resolve all problems in corneal grafting. Although 
we obtained a high VA in our study, even with spectacles, the magnitude of the induced 
astigmatism still remains unpredictable.7 Because early suture removal may result in 
unpredictable changes in astigmatism, our policy is not to remove all sutures until 2 to 
3 years after surgery. The second potential disadvantage of this mushroom keratoplasty 
is the difficulty of the technique, which requires a skilled surgeon. Compared with PK, 
b
a
Fig 3. Keratoplasty in a recipient cornea with a thin periphery. (J Leenen)
A, Problematic wound healing of a normal thickness donor cornea to a 1-sided thin recipient in 
conventional keratoplasty with a vertical cut.
B, Mushroom graft to a 1-sided thin recipient; no dislocation occurs.
(See also Colour Figures, p. 140.)
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the procedure time of a mushroom keratoplasty is longer. To facilitate the procedure, 
a femtosecond or excimer laser might be used to incise the cornea. Laser trephination 
could have the potential to improve the visual outcome by creating congruent cut 
edges parallel to the optical axis, resulting in a higher regularity of the corneal topog-
raphy.31,43-48 No significant difference in endothelial cell density was found between the 
mechanical and nonmechanical technique.46
In conclusion, the mushroom keratoplasty can be used in patients with advanced 
KC. This technique is especially useful in steep corneas with a thin periphery in the re-
cipient cornea. Our short-term results in this limited series of patients are encouraging. 
The extent of the corneal astigmatism after the removal of all sutures must be studied 
further. More studies with larger patient groups are needed to draw strong conclusions 
regarding the long-term effects of mushroom keratoplasty in KC patients.
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Purpose: To analyze endothelial cell density (ECD) decay after Descemet’s Stripping Au-
tomated Endothelial Keratoplasty (DSAEK) and top-hat keratoplasty (THPK) in patients 
with Fuchs’ endothelial dystrophy (FED) and/or pseudophakic bullous keratopathy 
(PPBK).
methods: Patients underwent either THPK (n = 33) or DSAEK (n = 39) at the Erasmus 
Medical Center, Rotterdam. For each non-randomized cohort a bi-exponential regres-
sion model for ECD decay was fitted. Factors associated with higher ECD decay were 
evaluated.
results: Median follow-up was 31.2 months (range 11 - 91) in the THPK cohort, and 23.4 
months (range 6 – 61) after DSAEK. The early ECD decay was much higher after DSAEK 
(half time 2.2 months) compared to THPK (half time 12.8 months). The late ECD decay af-
ter DSAEK was less steep (half time 75.5 months) than after THPK (half time 62 months). 
The 1-, 3- and 5-year endothelial cell losses derived from the models were after DSAEK: 
56%, 66% and 73%, respectively; and after THPK: 24%, 50% and 64%, respectively. For 
both cohorts PPBK as indication for surgery was associated with significantly higher 
late-phase decay rates. Fuchs endothelial dystrophy and same-session cataract surgery 
were confounding variables in the DSAEK cohort. Regarding DSAEK, postoperative 
re-bubbling was not found to have significant effects on early or late ECD decay rates. 
However, limited sample size and other limitations related to our method of evaluation 
may have influenced these findings.
Conclusions: After DSAEK early ECD decay was stronger, as opposed to late decay that 
was faster after THPK and in case of PPBK.
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IntroDuCtIon
Penetrating keratoplasty (PK) has been the standard of care for treating endothelial 
failure for many years. The posterior mushroom or top-hat penetrating keratoplasty 
(THPK) is a type of PK with a stepped wound configuration, in which the posterior donor 
diameter of the transplant (and the recipient wound bed) is larger than the anterior 
donor and recipient diameter.1 This technique has successfully been used for the treat-
ment of Fuchs’ endothelial dystrophy and pseudophakic bullous keratopathy.2 Due to 
the large posterior diameter of the transplanted cornea, a higher percentage of diseased 
endothelium is replaced compared to standard PK. Also, the self-sealing posterior lip 
provides a better wound stability.
Currently, Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) has 
replaced PK as the gold standard surgical treatment for corneal endothelial disorders.3 
Its main advantages include the lack of sutures, less induced (irregular) astigmatism 
and hence a faster visual recovery. Furthermore, it is a safer technique with less risk for 
expulsive hemorrhage and no suture related complications. However, a main concern 
with this technique, especially regarding long-term results and long-term graft survival, 
remains the rate of postoperative endothelial cell loss. 4-6
Recently Price et al7 showed that overall graft success was comparable for DSAEK and 
PK procedures. However, the endothelial cell loss was higher after DSAEK at 6 and 12 
months postoperatively, consistent with endothelial trauma caused by more donor tis-
sue manipulation.8 In this study, relative endothelial cell loss was found to be 34 ± 22 % 
for DSAEK vs. 11 ± 20 % for PK at 6 months postoperatively, and 38 ± 22 % vs. 20 ± 23 % 
at 12 months.
The first aim of our present study was to evaluate endothelial cell loss and analyze 
endothelial cell decay patterns in two groups of patients operated in our own institution 
(Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands). 
Patients underwent either THPK or DSAEK. We set out to fit bi-exponential endothelial 
regression models for endothelial cell decay, comparable with the biphasic models previ-
ously described by Armitage et al.9 and Böhringer et al.10 The second aim was to identify 
factors associated with faster or slower endothelial cell decay in both the early and late 
postoperative phases after both types of corneal transplantation. Therefore, additional 
analyses were performed to evaluate the effect of several pre-, intra- and post-operative 
factors on the decay rate coefficients of the early and late phases of both models.
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THPK has been performed in the Department of Ophthalmology of the Erasmus Medical 
Center Rotterdam since March 2003. DSAEK has been performed in our department 
since October 2004. After October 2004, indications for THPK were: endothelium-related 
corneal disorders with concomitant stromal opacities, endothelial disorders in patients 
without any crystalline lens opacities, and pseudophakic bullous keratopathies (PPBK) 
in case of an absent or ruptured posterior capsula (because of the risk of air dislocation 
to the posterior segment when performing DSAEK). Patients with persistent stromal and 
epithelial edema resulting in the formation of microcysts with or without bullae are both 
called PPBK. Only patients with persistent stromal edema were operated. Preoperative 
pachymetry measurements were not routinely performed.
 The medical records of all patients that had undergone DSAEK or THPK, for either 
Fuchs’ endothelial dystrophy (FED) or PPBK or both, at the Erasmus Medical Center, 
Rotterdam, The Netherlands, were reviewed. The few cases with other indications (e.g. 
re-graft) and/or more extensive concomitant pathology besides FED or PPBK were ex-
cluded from this study, as were cases with a completed follow up of less than 6 months 
were excluded. Our study includes the initial experiences with each respective surgical 
technique of both surgeons who started performing these techniques (GVR and MCB).
The main outcome measures in this study were endothelial cell densities (ECD), ob-
tained at different (flexible) follow up time points. The endothelial cell densities had 
been prospectively and longitudinally measured after transplantation, using a Topcon 
SP3000P non-contact specular microscope and semi-automated endothelial cell analy-
sis with Topcon Imagenet Endothelial Cell analysis software (Topcon Europe Medical 
B.V., The Netherlands).11
Two cohorts, DSAEK and THPK, were identified and data were separately analyzed for 
each cohort. Besides ECD, also surgeon, date of surgery, whether or not simultaneous 
cataract extraction had been performed (either with a routine phacoemulsification (MB) 
or a Blumenthal manual extracapsular technique (GVR)), and postoperative complica-
tions were recorded.
Cases with clinically manifest endothelial rejection episodes during the postoperative 
follow-up window were excluded before analysis.
DSaEk surgical technique
DSAEK cases were performed under either general or retrobulbar block anesthesia, by 
2 surgeons (GVR and MCB). The surgical technique is in many ways comparable to the 
technique used by Price et al.12 A superiorly located corneoscleral tunnel incision of 
5.5 to 6.0 mm was used in all cases. The incision was sutured water-tight at the end of 
the procedure and covered with conjunctiva. In all cases, the donor posterior lamella 
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was cut intra-operatively from a corneoscleral donor disc, using a Moria Evolution 2 
Microkeratome system with a 350 μm head on an artificial anterior chamber (Moria, 
Paris, France). All donor corneas had been preserved in organ culture medium at 31 
degrees Celsius and were obtained from Bio Implant Service, Leiden, The Netherlands. 
A donor lamella of 8.5 mm was transplanted. In all cases, an anterior chamber main-
tainer was used during Descemetorhexis and during donor lamella insertion, to prevent 
anterior chamber collapse. A drop of viscoelastic substance (Healon®) was applied on 
to the donor endothelium prior to introduction of the donor lamella into the anterior 
chamber. No additional viscoelastic material was used. Donor insertion was performed 
with a pull-through technique using a prolene 10.0 nylon suture on Sabreloc Straight 
Transchamber needles (Ethicon, Auneau, France). The very first two donor insertions had 
been performed with forceps and in one later case the Busin glide and forceps were 
used.13 Both cases with forceps insertion and the case with Busin glide insertion were 
excluded from this study before analysis, in order to provide a more homogeneous data 
set before analysis.
additional DSaEk data
For the DSAEK group, other parameters included in the analysis were: indication for 
surgery (FED, PPBK, or both); concomitant cataract surgery with the DSAEK-procedure 
(yes or no); duration of high-pressure complete air fill (10 vs. 15 minutes) for donor 
attachment; suturing of the posterior lamella with one suture at 12 o’clock onto the 
anterior stroma (yes or no); late post-operative elevated intraocular pressure (IOP) (yes 
or no); whether or not a post-operative “re-bubbling” had been performed for (partial) 
donor detachment (yes or no); and a newly devised score to evaluate intra- and early 
post-operative manipulation of donor material. Using the “DSAEK-score“, we evaluated 
intra-operative and post-operative donor lamella manipulation in DSAEK surgery. This 
score is an ordinal summation score, which had specifically been devised by us (GVR 
and MCB) for this purpose. In this score, points are added when more than normal 
manipulation of donor tissue occurred during preparation and insertion of the donor 
lamella. More points are added when post-operative “re-bubbling” procedures had to be 
performed for donor lamella detachment. (Table 1)
tHPk surgical technique
All THPK cases were performed under general or retrobulbar block anesthesia by 2 
surgeons (GVR and MB). The top hat surgical technique has been described in detail.2 
Either 16 interrupted, or 8 interrupted and 1 running 10-0 nylon sutures were used. No 
other intra-operative complications occurred in the included cases.
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Donor endothelial diameter was looked into; however all included cases had an endo-
thelial diameter of 9.0 mm except 5 cases in which the endothelial diameter was slightly 
smaller (8.5 mm n=2; 8.75 n=3). Statistical evaluation of these 2 tiny subgroups was 
deemed not feasible.
Analyzed parameters included: suturing technique (16 interrupted vs. 8 interrupted 
plus 1 running suture), concomitant cataract surgery (same types as in DSAEK) during 
the THPK (yes or no), and later post-operative suture related procedures (either suture 
addition or complete suture removal; yes or no for any “suture procedure”).
Statistical model
Longitudinal ECD-measurements (number of cells per square mm) were taken at various 
times within patients after cornea transplantation. In order to analyse ECD-decay over 
time a two-compartment exponential decay model was used. The parameters of that 
model were estimated using nonlinear mixed modelling (PROC NLMIXED of SAS, version 
9.2, SAS, Gary, In). NL MIXED uses an improved maximum likelihood estimation method 
and can therefore deal with missing values; there is no need for imputing data.
The variable to be explained by that model is defined as the remaining ECD-fraction 
at time t in patient : ECDti / ECD0i, with t measured in months. This fraction by definition 
equals 1 at time 0.
The two-compartment exponential decay model is specified as follows:
 ECDti / ECD0i = ci × exp(at) + (1 – ci) × exp(bt) + uti
For numerical purposes the term ci is re-parameterized as a logistic function:
 ci = exp(δi) / (1 + exp(δi)),
so that 0 < ci < 1. The parameters a < 0 and b < 0 are the monthly decay rates (coef-
ficients) that are assumed constant in time and between subjects. For each patient i the 
table 1. DSAEK score
Microkeratome cutting problems
Insertion of donor lamella for a second time
Insertion of donor lamella more than 2 times
Manipulation needed for unfolding the donor lamella
Graft upside down, reversal of graft performed.
Remaining air bubble (partial fill) in AC after the procedure
Insufficient intraoperative adherence after initial air fill, further air fill
First postoperative re-bubbling
Second postoperative re-bubbling
1
1
2
1
2
1
1
2
3
(AC: anterior chamber)
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term di is supposed to be drawn from a normal distribution with mean δ and variance Vd, 
representing the between-patient variability of the total decay functions. At each time 
t and within each patient i the residual term uti is supposed to be drawn from a normal 
distribution with mean 0 and variance Vu, representing the within-patient variability of 
ECD-fractions around the patient’s own total decay function.
The parameters to be estimated are a, b, δ, Vd and Vu. A 95% reference interval for the 
ci-terms across subjects is given by exp(δ ± 1.96√Vd) / (1 + exp(δ ± 1.96√Vd)).
The effect of possibly influencing factors, so-called explanatory variables xi of patient 
i on his total decay function is exploratively analyzed by specifying the monthly decay 
rates a and b as linear functions of xi:
 a(xi) = a0 + a1xi and b(xi) = b0 + b1xi.
Due to scarcity of data (small number of patients and small numbers of measurements 
per patient relatively to the number of parameters to be estimated), those effects are 
estimated for each explanatory variable xi and for either parameter a and b separately.
rESuLtS
Patient data
In the THPK-cohort eventually 33 cases were included (Table 2). In 6 out of 33 cases, 
concomitant cataract surgery was performed in the same session, either immediately 
prior to or during THPK surgery. In 11 cases only interrupted sutures were used, in the 
remaining 22, 8 interrupted and 1 running suture were used. In 5 out of 33 cases, late 
post-operative suture-related procedures (either suture addition or complete suture 
removal) were performed.
In our DSAEK cohort eventually 39 cases were included (Table 2). In 20 cases, concomi-
tant cataract surgery was performed in the same session, immediately prior to DSAEK. 
In 7 out of 39 cases, complete air fill was performed for 15 minutes, in the remaining 32 
cases, complete air fill was performed for 10 minutes. Suturing of the posterior lamella 
table 2. Patient data
Patient group Diagnosis
THPK (n = 33) FED (n = 17)
PBBK (n = 10)
FED/PBBK (n = 6)
DSAEK (n = 39) FED (n = 22)
PBBK (n = 10)
FED/PBBK (n = 7)
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occurred in 9 out of 39 cases. In 11 cases, one re-bubbling procedure was necessary, and 
in 2 more cases a second re-bubbling was performed; for purpose of statistical analysis 
we evaluated a group of 13 cases in which one or more re-bubblings were performed. 
Out of 39 cases, 21 cases had a DSAEK-score of 1. Seven cases had a score of 2, 8 cases 
had a score of 3, 2 cases had a score of 4, and 1 case had a score of 5. Postoperatively 
elevated IOP was observed in 6 out of 39 cases.
In our THPK cohort, in two cases a secondarily failed graft (not related to endothelial 
rejection) occurred: in one patient 4 years after transplantation and in the other patient 
at 2 years after transplantation. These cases were included in the model with an as-
sumed last ECD of 0 cells/mm2. In the DSAEK group, no secondary failed grafts occurred. 
Primary graft failures were not observed at all.
Median follow-up for the THPK cohort measured 31.2 months (range 11 - 91) and 23.4 
months (range 6 – 61) for the DSAEK cohort.
regression models of ECD decay and descriptive statistics
The estimated parameters of the global two-compartment exponential decay model are 
presented in table 3 for DSAEK and THPK.
 ECDti / ECD0i = ci × exp(–at) + (1 – ci) × exp(–bt) + uti
with ci = exp(δi) / (1 + exp(δi)),
The estimated means and 95 % reference intervals of the ci-terms across subjects for 
DSAEK and THPK are given by 0.472 (0.159-0.808) and 0.636 (0.447-0.791) respectively.
In DSAEK, a = -0.00918 is the estimated monthly decay-rate coefficient of the late 
phase, and b = -0.3102 is the estimated decay rate of the early phase. ECD decay half 
times for DSAEK were calculated as ln(2)/0.00918 = 75.5 months for the late phase and 
as ln(2)/0.3102 = 2.2 months for the early phase.
In THPK, a = - 0.01030 is the estimated decay rate of the late phase, and b = -0.04222 
is the estimated decay rate of the early phase. ECD decay half times for THPK were calcu-
table 3. Estimated parameters of the global two-compartments exponential decay model for DSAEK and 
THPK.
Parameter DSAEK estimate (95 % CI) THPK estimate (95 % CI)
a –0.00918 (–0.01239 to –0.00598) –0.01030 (-0.02114 to +0.000530)
b –0.3102 (–0.4258 to –0.1945) –0.04222 (-0.07873 to – 0.00571)
δ –0.1135 (–0.4378 to 0.2108) 0.5585 (0.02073 to 1.0962)
Vd 0.6278 0.1542
Vu 0.001193 0.007536
(CI: confidence interval)
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lated as ln (2)/0.01118 = 62.0 months for late phase, and as ln(2)/0.05401 = 12.8 months 
for early phase.
Using the models with estimated parameters a, b and δ, ECD-decay graphs depicted 
in Figure 1, starting at an average ECD-level set at 2736 cells/mm2. Both graphs were 
extrapolated to a follow- up of 10 years postoperatively. Our longest actual follow-up 
durations were 91 months in the THPK group and 61 months in the DSAEK group.
From these extrapolated models it was calculated that on average our THPK cohort 
would reach the 500 cells/mm2-mark at 118 months postoperatively, and the DSAEK 
cohort at 103 months post-operatively.
Using the estimated models also the 1, 3 and 5-year endothelial cell loss can be pre-
dicted. The 1, 3 and 5-year endothelial cell loss after DSAEK measured 56%, 66% and 
73%, respectively. The 1, 3 and 5-year endothelial cell loss after THPK measured 24%, 
50% and 64%, respectively.
Possibly influencing factors
The effect of possibly influencing factors (explanatory variables) xi of patient i on his 
total decay function was explorative analyzed by specifying the monthly decay rates a 
(late phase) and b (early phase) as linear functions of xi:
 a(xi) = a0 + a1xi and b(xi) = b0 + b1xi.
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Fig 1. ECD decay graphs for DSAEK and THPK.
(Arrows indicate longest actual follow-up time in both groups; 91 months in the THPK group and 61 
months in the DSAEK group.)
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These effects were estimated for each explanatory variable xi and for either parameter 
a and b separately. For example, when xi = 0 or 1, respectively denoting no or yes FED-
indication, then a0 is the late ECD decay rate without FED-indication and the sum a0 + 
a1 is the late decay rate with FED-indication, the difference in late decay rates being 
represented by a1.
a) THPK
The effect of the indication FED for keratoplasty was neither significant on early- or 
late-phase ECD decay rates. However, when PPBK was the indication surgery, the decay 
rate of the late phase was significantly weaker (i.e., less negative) than that of non-PPBK 
THPKs (–0.00570 vs –0.01464; p=0.001), whereas PPBK as indication for surgery had no 
significant effect on the early phase decay rate. When PPBK combined with FED was 
the indication, again the late phase decay rate was significantly weaker (–0.00362 vs 
–0.01409; p = 0.0002); this was not so for the early phase decay rate.
Neither suturing technique nor late post-operative suture-related procedures had a 
significant effect on either early or late ECD decay rates.
Simultaneous cataract surgery during THPK had no significant effect on late phase ECD 
decay; however the early-phase ECD decay rate was found to be significantly weaker in 
cases with simultaneous cataract extractions (–0.02586 vs –0.05265; p= 0.0044).
b) DSAEK
When FED was the indication for DSAEK, the late phase ECD decay rate was significantly 
weaker (i.e., less negative) than in non-FED DSAEKs (–0.00852 vs –0.01962; p=0.0001). 
The effect of FED as indication for DSAEK on the early phase decay rate could not be es-
timated, probably because none of the 10 non-FED subjects had more than three visits. 
Late phase decay rate was significantly stronger (i.e., more negative) in PPBK DSAEKs 
compared to non-PPBK DSAEKs (–0.01524 vs –0.00784; p=0.0026); no significant effect 
of PPBK as indication for surgery was found on early phase decay. Simultaneous FED 
and PPBK as indication had no significant effects on either early or late phase ECD decay 
rates.
A difference in the duration of complete air fill for donor lamella adherence of 5 min-
utes (10 vs. 15 minutes complete fill) did not cause a significant difference in early or 
late ECD decay rates. Neither did the fact whether the donor lamella was sutured to the 
anterior recipient stroma or not.
Same-session cataract surgery (cataract surgery immediately prior to DSAEK) caused a 
significantly weaker late-phase ECD decay rate (–0.00785 vs –0.01512; p=0.0039), but no 
significant difference in early-phase ECD decay rate. (Late) post-operative IOP elevation 
had no significant effects on either late or early phase ECD decay rates.
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The fact whether one or more re-bubbling procedure had to be performed to obtain 
definitive donor lamella adherence, was not found to have significant effects on either 
early or late phase ECD decay rates. Each additional point in our DSAEK score (i.e. small 
increases in the perceived amount of donor tissue manipulation before, during, and/or 
after donor lamella insertion) increased the ECD decay rate coefficients of both the early 
and late phases a little bit, but these effects were not significant.
DISCuSSIon
In our study we were able to fit a single regression equation for endothelial cell decay 
to the complete data set of each technique. Our regression model took both repeated 
intra-patient measurements, and inter- and intra-patient variance into account. We did 
not have to use imputed data, such as was done in the study by Böhringer et al.10 Even 
although the patients in our study had not been randomly assigned to one of each 
transplantation techniques - rather our cohorts were each other’s historical control 
groups – comparing the different decay coefficients still allowed for in-depth compari-
son of endothelial cell decay between both groups.
Our results show that the early-phase postoperative endothelial cell loss in DSAEK is 
much higher and faster (decay half time was 2.2 months) compared to THPK (half time 
12.8 months). This finding is in line with previously reported results, and is consistent 
with the conclusion that more endothelial trauma occurs in endothelial keratoplasty, 
due to more donor tissue manipulation.14 The opposite is true for the late-phase endo-
thelial cell loss; after DSAEK the late phase decay of endothelial cells was less steep than 
after THPK (Fig 1). Late phase ECD decay half time in DSAEK was 75.5 months vs. 62.0 
months for late phase THPK half time. This also is consistent with earlier findings. 15
Compared to other reported results on ECDs after DSAEK, the early phase endothelial 
cell losses in our study appeared to be higher. This may be explained by our learning 
curve; our data included the very first DSAEK cases performed in our center. In contrast, 
in our study no significant effect on ECD decay of more donor tissue manipulation (the 
“DSAEK score”) could be demonstrated. However, it should be noted that we were only 
able to test the effect of a 1-point-increment on the DSAEK-score. Such a small incre-
ment in score in fact did result in a slightly higher decay rate coefficient (either early or 
late phase), but this was not a significant effect. Stronger effects of higher manipula-
tion scores may be expected and were suggested by our raw data, but this could not 
be tested with our statistical analysis methods. We could also not demonstrate that 
re-bubbling procedures were detrimental to the endothelial cell decay rates. Similarly, 
other authors have also not been able to demonstrate higher endothelial cell losses 
after re-bubbling procedures.16 The re-bubbling rate in our study was remarkably high 
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(up to 30%). Since these re-bubblings occurred predominantly in the first 15 cases, a 
learning curve in surgical technique and/or intra-operative donor tissue preparation is 
highly likely. There were no differences regarding donor tissue handling or preservation 
techniques in the non-attached cases.
In the THPK cohort, as expected, no relation was found between early or late endo-
thelial cell loss rates and suturing techniques (continuous vs. interrupted). Late post-
operative suture related procedures (additional suture placements or removal of all 
sutures) were also not found to be detrimental on ECD decay rates, possibly because no 
endothelial rejections or other major events such as dehiscence were induced.
Performing simultaneous cataract extraction caused a significantly lower early endo-
thelial cell loss rate in THPK. This is not an easy finding to explain. Deepening of the 
anterior chambers may occur after recent cataract surgery, which in turn may lead to a 
decrease in early phase endothelial cell loss rate. Circumstantial evidence for this pos-
sible explanation can be found in increased endothelial cell loss when shallow anterior 
chambers after trabeculectomy surgery occur,17 or increased endothelial cell loss after 
hypermetropic anterior chamber iris attached phakic IOLs,18 or when glaucoma drainage 
tubing is in close proximity to the endothelium.19 However, anterior chamber depths 
were not measured and hence this explanation is merely conjecture.
In both the DSAEK and THPK cohorts, the diagnosis of PPBK was associated with a 
significantly higher late phase endothelial cell loss rate. In addition, after DSAEK (but 
not after THPK) the late phase ECD decay rate was significantly lower when FED was 
the indication for surgery. In 20 of the 22 patients with FED, DSAEK was combined with 
same-session cataract extraction. The variable “intra-operative cataract surgery” there-
fore is highly confounded with the indication FED. Interpretation of separate effects of 
both variables on ECD-loss after DSAEK therefore is not possible.
These findings support the hypothesis that the often reported higher than physi-
ological late–phase ECD loss after corneal transplantation might be caused by the 
phenomenon of endothelial cell redistribution onto the recipient cornea. Redistribu-
tion of endothelial cells onto the recipient cornea is supposedly stronger in cases of 
PPBK where the recipient endothelium has been largely or completely depleted, than 
in (phakic) cases with FED with better peripheral recipient endothelium. In the recent 
study by Böhringer et al., PKP for keratoconus (with healthy recipient endothelium), was 
shown to have lower late phase ECD losses than cases with PPBK. 10 These findings are 
also consistent with earlier findings that (PK) graft survival in PPBK is lower compared to 
keratoconus and FED.15
As Böhringer et al. pointed out, redistribution of donor endothelial cells to the recipi-
ent cornea is not only responsible for high late phase endothelial cell decay rate, i.e. for 
higher than physiological loss, but (hence) also for the development of Late Endothe-
lial Failure of grafts. The concept of Late Endothelial Failure of a corneal graft was first 
Isabelle BW.indd   74 09-Sep-11   12:23:12 PM
Endothelial cell decay after DSAEK and Top Hat Keratoplasty 75
recognized by Polack 20 and defined by Bourne.21 Bourne and Armitage described Late 
Endothelial Failure as a function of the higher than physiological ECD decay in the late 
phase after transplantation, and also of the level of ECD at which this higher than physi-
ological decay starts.10, 17 When initial ECDs are already low, increased decay will cause 
Late Endothelial Failure sooner. The results in our DSAEK cohort present us with some 
concerns in this respect.
The rate of endothelial cell loss tapered off more after DSAEK than after THPK. The 
reason for this difference between late endothelial cell loss rates is yet unknown. The 
inflammatory response might be less after DSAEK due to the smaller wound,22 and this 
may be akin to the theory that chronic subclinical inflammation and/or a chronically 
broken-down blood-aqueous barrier may the cause of increased late cell loss after (TH)
PK.10 The differences between the wounds may also cause differences in mechanical 
stability of the globe and hence differences in mechanical forces causing endothelial 
attrition. Finally, the edge of the DSAEK onlay graft protruding into the anterior chamber 
might function as physical barrier that inhibits endothelial cell migration onto the recipi-
ent.23 Endothelial cell migration does occur after DSAEK, as was recently demonstrated 
by Stewart et al.,24 but due to this physical barrier it may be slower and more fragile than 
after PK. After THPK such a physical barrier for endothelial migration may be less of a 
factor and the endothelial cells may migrate more freely.
In the near future, analyses of longer-term results of other recent studies published on 
ECD loss after DSAEK15 will further elucidate patterns of prolonged increased endothelial 
cell loss and the rate of Late Endothelial Failure after DSAEK. It will be interesting to also 
investigate late phase endothelial cell loss rates and Late Endothelial Failure rates after 
the newly emerged Descemet’s Membrane Endothelial Keratoplasty (DMEK) technique. 
After DMEK, early endothelial cell loss due to pre-operative and intra-operative tissue 
manipulation appears to be similar compared to DSAEK,25 but much less of a physical 
barrier for late endothelial migration may be present than after DSAEK.26
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A posterior Khodadoust line in a graft 
rejection episode after Descemet Stripping 
Automated Endothelial Keratoplasty
Saelens IEY, Bleyen I, Bartels MC, Rij Van G.
Cornea 2011; 30:245-246.
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abStraCt
Purpose: To describe the presence of an endothelial rejection line in immunological 
graft rejection after Descemet Stripping Automated Endothelial Keratoplasty (DSAEK).
methods: Case report.
results: A 77-year-old woman underwent DSAEK procedure of the left eye because of 
visual limiting bullous keratopathy. One week postoperatively, the donor lamella was 
partially detached and an additional air bubble was injected into the anterior chamber. 
Thereafter, complete adherence of the lamella was seen. Four months after surgery 
vision deteriorated and a transient immunological graft rejection episode with endo-
thelial rejection line was seen.
Conclusion: In contrast to other reports, an endothelial rejection line (Khodadoust line) 
can be seen during the endothelial rejection episode after DSAEK.
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IntroDuCtIon
Microkeratome-assisted Descemet Stripping Automated Endothelial Keratoplasty 
(DSAEK) is a form of lamellar corneal surgery that allows for the selective replacement of 
diseased endothelium. The most common complications after DSAEK include posterior 
graft dislocations, primary graft failure, iatrogenic glaucoma, and endothelial graft rejec-
tion.1 A recent study compared immunological graft rejection episodes after DSAEK and 
penetrating keratoplasty; no endothelial rejection line (Khodadoust line) was observed 
in 54 eyes that experienced a graft rejection episode after DSAEK.2 We present a case of 
an immunological graft rejection episode four months after DSAEK with an endothelial 
rejection line.
CaSE rEPort
A 77-year-old woman was referred to our cornea clinic with complaints of reduced 
visual acuity of the left eye. Biomicroscopy showed endothelial guttata in both eyes and 
central corneal edema in the left eye. Funduscopy revealed no abnormalities. Her ocular 
history included a refractive amblyopia of the left eye, a cataract extraction in both eyes 
with Worst claw lens implantation in the right eye, and a standard posterior chamber 
intraocular lens in the left eye. The best-corrected visual acuity of her right eye was 0.4 
and of her left eye was 0.16. A DSAEK was performed under general anesthesia at the left 
eye. Endothelial cell count of the donor cornea measured 2700 cells/mm2. The patient 
was asked to use dexamethasone phosphate 0.1% (Dexamethason) eye drops 6 times 
daily for 2 months and chloramphenicol 0.5% (Chloramphenicol) eye drops 3 times daily 
for 1 week.
One week postoperatively, the posterior lamellar graft was detached; an additional 
air bubble was injected into the anterior chamber 13 days postoperatively. Thereafter, 
complete adherence of the lamella was seen. Four weeks after the DSAEK-procedure, 
visual acuity measured 0.2 with a spherical correction of +2 diopters (D). The patient was 
asked to continue the dexamethasone eye drops 6 times a day. The patient was referred 
to her own ophthalmologist for further follow-up visits.
Our patient was instructed to use the dexamethasone phosphate 0.1% eye drops 6 
times daily for the first 8 weeks postoperatively, and then switch to 4 times daily. Here-
after, drops are tapered off by 1 drop per month until 1 drop a day is reached. We advise 
patients with pseudophakia to use 1 drop a day lifelong.
Four months postoperatively, the patient was again referred to our department with 
progressive blurring of vision and a mild irritation of the left eye. Visual acuity of the 
left eye was hand movements only. Slit-lamp examination showed severe and extensive 
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stromal edema and keratic precipitates, limited to the graft, forming a typical posterior 
Khodadoust line (Fig 1).3 The posterior lamella was attached. The patient revealed that 
she had been avoiding further follow-up visits with her own ophthalmologist and had 
discontinued the dexamethasone eye drops 4 weeks after the DSAEK. Therapy with 
prednisolone acetate 10% (Pred Forte) eye drops 6 times daily, atropine 1% once daily, 
and prednisolone pivalate 5% (Ultracortenol) eye gel at night time was started. One 
week later, the Khodadoust line had disappeared; stromal edema and keratic precipi-
tates were still present. One month later, the corneal graft partially cleared with stromal 
edema at the central 1.5 mm. Best-corrected visual acuity measured 0.2 (S +2D).
ConCLuSIon
In our patient, the DSAEK was complicated by an immunological graft rejection episode 
with endothelial rejection line (Khodadoust line). The site of origin of an endothelial 
rejection line has been associated with the vascularization of the cornea.4 Jordan et al2 
attributed the absence of endothelial rejection lines in his group of patients to the lack 
of stromal vessels extending into the graft tissue. They suggested that the immuno-
logical rejection process in DSAEK might be initiated via the anterior chamber instead 
of stromal vascularization. In our patient, no vascularization was present. When steroids 
are suddenly stopped shortly after surgery, the few lymphoid cells in the aqueous might 
multiply and form an endothelial rejection line. Our case illustrates that an endothelial 
rejection line can be observed after DSAEK, independent of graft vascularization.
Fig. 1. Khodadoust line
(See also Colour Figures, p. 140.)
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We would like to emphasize the importance of clear patient instructions concerning 
the use of eye drops and possible rejection signs, especially when topical steroids are 
tapered off. In general, initial graft rejection leads to mild symptoms only, which can 
contribute to an important patient delay.
In conclusion, we describe a case of immunological graft rejection with endothelial re-
jection line 4 months after DSAEK. Contrary to our instructions, the patient had stopped 
using the steroid eye drops at 1 month postoperatively, and she did not visit her own 
ophthalmologist.
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Introduction of epithelial cells in the flap-graft 
interface during Descemet Stripping 
Automated Endothelial Keratoplasty
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IntroDuCtIon
Microkeratome-assisted Descemet Stripping Automated Endothelial Keratoplasty 
(DSAEK) is a form of lamellar corneal surgery that allows for the selective replacement of 
diseased endothelium. 1-3 The DSAEK procedure is relatively new. So far, few complica-
tions have been described; these include graft detachment and graft failure.4 Recently, 
epithelial ingrowth in the flap-graft interface after DSAEK has been reported.5 We report 
a case of introduction of epithelial cells, originating from the donor tissue, in the flap-
graft interface.
rEPort oF a CaSE
In May 2005, a 67-year-old woman visited with pseudophakic bullous keratopathy in 
the right eye. Best-corrected visual acuity was 0.08 OD. Because of the vision-limiting 
bullous keratopathy in the right eye, a DSAEK was performed under general anesthesia. 
A cornea from a male donor was used.
One week postoperatively, the posterior lamellar graft was detached inferiorly and 
nasally. An additional air bubble and two 10-0 nylon sutures were placed to fixate the 
transplant. Thereafter, partial adherence of the lamella was seen.
Four months postoperatively, the graft was attached and best-corrected visual acuity 
improved to 0.63 OD, with −1.00. Between the 3-o’clock and 6-o’clock positions, anterior 
synechia were present and the interface was slightly hazy. During regular follow-up, the 
abnormalities remained stable under fluorometholone, 1%, eye drops. The intraocular 
pressure remained between 10 and 17 mmHg during follow-up.
One year after DSAEK, the patient had progressive blurring of vision to hand move-
ments. We observed total corneal decompensation with bullae and Descemet mem-
brane folds. Therapy with prednisolone acetate, 10%, eye drops (Pred Forte) 6 times a 
day, prednisolone pivalate, 5%, eye gel (Ultracortenol) 3 times a day, and preservative-
free chloramphenicol, 0.4%, eye drops 3 times a day proved to be unsuccessful. A 
penetrating posterior mushroom keratoplasty was performed. Six months after surgery, 
best-corrected visual acuity improved to 0.80 OD with -3.25 C-2.0 x 30°. The corneal graft 
in the right eye has remained clear.
Histopathologic examination of the removed corneal button demonstrated 2 cysts at 
the interface between the recipient cornea and the donor stroma (Fig 1A). One cyst was 
lined by squamous epithelium; a smaller, centrally located cyst contained eosinophilic 
granular material. The Descemet membrane with some excrescences was incarcerated 
in the surgical scar. There was bullous keratopathy of the corneal epithelium. On im-
munohistochemistry, the lining of the cyst as well as the granular material stained 
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strongly positive for the epithelial markers 34Be12 and keratin 5/6, identical to surface 
epithelium (Fig 1B). The granular material was consistent with degenerated epithelial 
cells. In situ hybridization with X and Y probes revealed 2 X chromosomes in the nuclei of 
the epithelium and the stroma of the recipient. The nuclei of the epithelium of the cyst 
wall contained 1 X chromosome and 1 Y chromosome (Fig 2).
CommEnt
In our patient, the DSAEK was complicated by introduction of epithelial cells along 
the interface. Her native Descemet membrane with Fuchs endothelial dystrophy was 
partially incarcerated in the surgical scar, similar to the earlier described case,5 suggest-
Fig 1. There are two cysts at the interface between the recipient cornea and the posterior endothelial 
graft tissue (A), and the lining of the cysts stains strongly positive for the epithelial markers 34Be12 and 
keratin 5/6 (B).
(See also Colour Figures, p. 141.)
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ing an invasive postoperative ingrowth process. The X-Y karyotyping revealed that the 
epithelial cells were of donor origin. The technique of posterior lamellar keratoplasty is 
relatively new and technically difficult, with a surgeon’s learning curve. The most critical 
step is the preparation of the posterior lamellar disc by hand or by use of a microkera-
tome.
We postulate that the donor epithelium was implanted during the preparation of 
the donor posterior lamellar disc and was introduced intraoperatively. If complete 
attachment of the donor posterior lamella is accomplished, ectopic epithelial cells in 
the interface might remain stable without proliferation. In a partially detached donor 
lamella, ectopic epithelial cells might proliferate along the recipient’s posterior cornea.6
Fig 2. In situ hybridization with X and Y chromosome probes revealed 2 X chromosomes (arrow) in the 
epithelium and the stroma of the recipient (A) and 1 X chromosome (arrow) in the epithelium of the cyst 
(B). C, The epithelium of the cyst wall contained 1 Y chromosome (arrows). D, There was no staining of the 
Y chromosome probe (arrow) in the tissue of the recipient.
(See also Colour Figures, p. 142.)
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Refractive, topographic and visual outcome 
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patients with progressive keratoconus
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abStraCt
Purpose: To report refractive, topographic and visual outcomes 12 months after same-
day treatment with corneal cross-linking and Ferrara intracorneal ring segments (ICRS) 
in eyes with progressive keratoconus (KC) and contact lens intolerance.
methods: This was a case serie of 7 eyes (7 patients) with progressive mild to moderate 
KC and contact lens intolerance undergoing implantation of Ferrara ICRS immediately 
followed by corneal cross-linking. Uncorrected visual acuity, best spectacle-corrected 
visual acuity, refractive error, pachymetry and keratometry were evaluated at 3, 6 and 
12 months of follow-up.
results: Mean follow-up was 11.7 ± 3.6 months (range, 5 – 17 months). Mean preop-
erative uncorrected visual acuity and best spectacle-corrected visual acuity were 0.10 
± 0.07 (range, 0.05 - 0.2) and 0.56 ± 0.08 (range, 0.5 - 0.7), respectively. One year after 
treatment, mean uncorrected visual acuity and best spectacle-corrected visual acuity 
measured 0.60 ± 0.24 (range, 0.32 – 0.9) and 0.82 ± 0.25 (range, 0.5 - 1.2), respectively. The 
mean spherical equivalent decreased significantly (p < 0.05) with 3.5 D. Mean K-values 
decreased from 46.81 ± 2.13 D (range, 44 – 51 D) to 43.97 ± 2.22 D (range, 42 – 47.5D), 1 
year after treatment. The average preoperative thinnest pachymetry measured 462 ± 46 
μm (range, 410 ± 546 μm) and did not change significantly after treatment. In patient 1, 
the inferior ICRS was removed 5 months postoperatively because of implant migration.
Conclusion: The combined treatment of corneal cross-linking and Ferrara ICRS is a safe 
procedure that may be considered in patients with progressive mild to moderate KC and 
contact lens intolerance.
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IntroDuCtIon
Keratoconus (KC) is a non-inflammatory corneal ectasia, which usually starts at puberty 
and progresses until the third to fourth decade of life. In the early stages, the refractive 
error resulting from the KC can be corrected with glasses or contact lenses. In more 
advanced forms of KC or in case of contact lens intolerance, several surgical options 
are available to improve visual acuity, including intracorneal ring segments (ICRS),1 toric 
phakic intraocular lens implantation,2 deep anterior lamellar keratoplasty (DALK)3 or 
mushroom keratoplasty.4 However, none of these surgical procedures effectively treat 
KC, and progression of the cone might continue.
Ferrara ICRS have been shown to improve contact lens tolerance and visual acuity 
in a select group of patients with mild to moderate KC.5 However, long-term follow-up 
shows that ICRS fail to provide a permanent flattening effect.6 In 2003, Wollensak et al7 
introduced collagen cross-linking (CXL) by the photosensitizer riboflavin and ultraviolet 
(UV) A-light as the first treatment that changes the intrinsic biomechanical properties 
of corneal collagen. To obtain both the visual benefit of the Ferrara ICRS and the po-
tential stabilizing effect of CXL on corneal ectasia, we combined these two treatment 
procedures. We evaluated refractive, topographic and visual outcomes at 3, 6 and 12 
months after treatment in eyes with progressive mild to moderate KC with contact lens 
intolerance.
matErIaLS anD mEtHoDS
Patients
Between November 2007 and November 2008, 7 eyes of 7 patients underwent UVA-
induced CXL immediately after Ferrara ICRS implantation on the same day. All patients 
had a progressive KC with contact lens intolerance, an average keratometry of less 
than 53 diopters (D), and a best spectacle-corrected visual acuity (BSCVA) more than 
0.4. We defined progression as a change in astigmatism or myopia of 1 D or more or a 
mean keratometric change of 1.5 D or more during the past 12 months. Patients with 
corneal scarring, corneal thickness less than 400 μm, and a mesopic pupil diameter 
larger than 5.5 mm were excluded. The surgical procedure and follow-up examinations 
were performed by the same two surgeons (M.C.B. and G.V.R.) at the Erasmus University 
Hospital Rotterdam. All patients were examined preoperatively and 3, 6, and 12 months 
after treatment using Javal keratometer (Haag Streit, Bern, Switzerland) and standard 
Snellen chart. Every 6 months, corneal topography was performed using the Pentacam 
Scheimpflug camera (Oculus Optikgeräte GmbH, Wetzlar, Germany). The Student t- test 
for paired data was used to compare preoperative and postoperative results.
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treatment procedure
The treatment procedure was conducted under sterile conditions in the operating 
room. Conservative-free oxybuprocaine eye drops (Chauvin Benelux, Brussels, Belgium) 
were applied as topical anesthesia. A circular Ferrara marker centered on the reflex of 
the microscope light on the central cornea was used to create two concentric circles 
on the cornea. The incision was made at the steepest meridian of the anterior corneal 
surface with a calibrated diamond knife set at 80% of the corneal thickness determined 
by Scheimpflug scanning slit tomography. Corneal pockets were then created with 
a spreader hook. One semicircular dissector was placed sequentially in the lamellar 
pocket and steadily advanced by rotational movement (counterclockwise and clock-
wise dissectors). After creation of the tunnels, the ICRS were inserted in the tunnels. 
Depending on the nomogram (Keraring, Mediphacos, Belo Horizonte, Brazil), one or 
two PMMA segments with variable thickness (150-250) were implanted in the corneal 
stroma.1
After the ICRS were implanted, riboflavine 0.1% solution in 20% dextran (Ricrolin, 
SOOFT Italia SRL, Montegiorgio, Italy) was applied every 3 minutes for 25 minutes on the 
cornea and injected in the intrastromal canals. Riboflavin penetration of the stroma was 
confirmed at the slitlamp. The central 8.5-mm cornea was then irradiated with UVA-light 
diodes (370 nm) for 30 minutes using 3mW/cm2. During the irradiation, riboflavine was 
further applied every 3 minutes. Finally, a therapeutic soft contact lens was applied. 
Postoperative medications included preservative free diclofenac sodium 1 mg/ml, 
ofloxacine 3 mg/ml and dexamethason monofree 1mg/ml 3 times daily. Once complete 
reepithelialization occurred, the contact lens was removed and ofloxacine eye drops 
were discontinued. Diclofenac sodium eye drops were discontinued after one week, and 
dexamethason eye drops were tapered off by one drop weekly.
rESuLtS
Seven eyes of 7 patients were included. The mean age of the patients was 33.31 ± 
9.05 years (range, 20 – 42 years). Mean follow-up was 11.72 ± 3.6 months (range, 5 - 17 
months). Ferrara ICRS implantation was uneventful in all eyes. Table 1 shows data of 
implanted Ferrara ICRS in each patient.
Patient 1 underwent explantation of the inferior ring segment 5 months postopera-
tively. Four months after treatment, the patient reported irritation in his left eye. Little 
migration of the inferior ring towards the incision was seen. There was a small epithelial 
defect at the site of the incision. Although the ring segment was not wholly extruded, 
we decided to explant the ring. Three months after explantation of the inferior ring, 
mean K-value increased with 1.7 D and remained stable until now. Compared with the 
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preoperative data, mean K and steep K-values were decreased by 1 and 3 D, respectively. 
The corneal pachymetry did not change until now.
Mean baseline uncorrected visual acuity (UCVA) and BSCVA were 0.10 ± 0.07 (range, 
0.05 – 0.2) and 0.56 ± 0.08 (range, 0.5 – 0.7), respectively. One year after treatment, mean 
UCVA significantly improved to 0.60 ± 0.24 (range, 0.32 - 0.9) and BSCVA to 0.82 ± 0.25 
(range 0.5 – 1.2). Three of our patients wear contact lenses, with a best contact lens-
corrected visual acuity of 0.87 ± 0.12. One patient was still contact lens intolerant, and 
two patients had no correction due to excellent UCVA. The safety index (ratio BSCVA 
postoperatively to BSCVA preoperatively) in this study measured 1.47 after one year. 
None of the treated eyes had a decrease in visual acuity. The mean preoperative spheri-
cal equivalent (SE) was – 4.16 ± 2.41 D (range 0.25 to –5.5D). One year after treatment, 
mean SE measured -0.68 ± 1.49 D (range 0.25 to -3.0D). Pre- and postoperative kerato-
metric results are shown in table 2. One year after treatment, the decrease in mean K 
and steepest K-values were 3.0 D (p > 0.05) and 3.6 D (p < 0.05), respectively. Q-value 
obtained by the Pentacam software, changed from -0.76 preoperative to -0.30 one year 
after treatment.
table 1: Data of the implanted Ferrara ICRS in each patient.
Patient Steep K (D) Flat K (D) Inferior ring (µm) Superior ring (µm)
1 52.6 * 60° 47 * 150° 250 150
2 46 * 10° 42 * 100° 200 200
3 48 * 120° 45 * 25° 150 150
4 49,5 * 40° 48 * 140° 150 150
5 47 * 40° 42 * 130° 200 200
6 48.25 * 160° 44,5 * 40° 200
7 50.5 * 30° 45 * 120° 200 200
(D; diopters)
table 2. Pre-and postoperative data.
Pretreatment 3 Months 6 Months 12 Months
UCVA 0.10 ± 0.07 0.40 ± 0.18 0.48 ± 0.29 0.60 ± 0.24
BSCVA 0.56 ± 0.08 0.53 ± 0.23 0.68 ± 0.22 0.82 ± 0.25
SE -4.16 ± 2.41 -1.67 ± 1.81 -1.79 ± 1.79 -0.68 ± 1.49
K steep 48.84 ± 2.23 44.79 ± 1.30 45.73 ± 2.24 45.21 ± 2.08
K mean 46.81 ± 2.13 44.77 ± 1.66 45.01 ± 2.34 43.97 ± 2.22
K astigm 4.05 ± 1.48 2.11 ± 1.46 1.44 ± 1.11 1.58 ± 0.85
(UCVA; uncorrected visual acuity, BSCVA; best spectacle-corrected visual acuity, SE; spherical equivalent, 
K; keratometry) Data are means ± standard deviation.
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DISCuSSIon
This prospective study describes the combination of Ferrara ICRS implantation with CXL 
as a safe and effective treatment option in patients with progressive KC and contact lens 
intolerance. The achieved visual and refractive results remained stable during follow-up.
In all 7 eyes presented in this study, an increase in UCVA was obtained. Three months 
postoperatively, the mean UCVA improved significantly and remained stable. Compared 
with the few studies published on Ferrara ICRS, mean UCVA in our 7 cases increased with 
more Snellen lines after combined treatment than after Ferrara ring segments alone.1,5,8 
None of the patients in our small study group is considered for corneal transplantation.
Our results on visual acuity are in line with the reported results of combined treatment 
of CXL and Intacs.10,11 However, our keratometric results are more favorable; we obtained 
a significant reduction of 3.6 D in steep K-value and a significant reduction of 2.4 D in 
keratometric astigmatism one year after treatment. Chan et al10 reported an average 
reduction of 1.9 ± 1.32 D in steep K and 1.34 ± 1.27 D in average K values 3 months after 
CXL combined with Intacs. Ertan et al11 showed an average reduction in keratometry 
of 2 D after CXL (without epithelial abrasion) combined with Intacs implantation. The 
larger flattening effect in our patients might be attributed by two factors. First, Ferrara 
ICRS provide a smaller optical zone of 5 mm, whereas Intacs are designed for an optical 
zone of 7 mm. Insertion closer to the center could theoretically induce a more flatten-
ing effect. Comparative studies between Intacs and Ferrara ICRS are necessary to prove 
that the greater reduction in keratometry readings in our study can be attributed to the 
type of ICRS. Secondly, El-Raggal12 showed in his comparative study that a significant 
greater reduction of keratometric values is obtained when ICRS insertion and CXL are 
performed in one session compared to two sessions. There was no significant difference 
regarding the UCVA, BCVA and refractive error.
The long-term stability of visual acuity and mechanical flattening of Ferrara ICRS has 
been recently studied.13 Intacs were used in previous reported long-term studies of ICRS; 
Alió showed an increase in keratometry readings between 6 and 36 months postopera-
tively.6 In our study group, no significant change in keratometry values between 6 and 12 
months postoperatively could be observed. Moreover, a further decrease of keratometry 
values between 6 and 12 months postoperatively is seen in our study group, although it 
was not significantly different in this small group of patients.
An alternative combination treatment focused on structural and refractive improve-
ment, is simultaneous topography-guided PRK and CXL.14,15 However, long term outcome 
is yet unknown. In contrast to PRK, intracorneal ring segment implantation is reversible.
Regarding postoperative complications of ring implantation, several events have been 
described; ring extrusion and migration,1,5,16 channel deposits,17 infectious keratitis18 and 
corneal melting.19 We only found one ring migration in patient with extreme eye rub-
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bing. During our follow-up, no other complication of CXL or ring implantation was seen. 
We hypothesize that the CXL procedure immediately after ICRS implantation might be 
attributable to a more stable ring placement with less migration of the ring segments.
In these seven patients, we did not use any eye drops with benzalkonium chloride, 
neither did we perform epithelial abrasion before CXL treatment. However, epithelial 
defects were proven at the ring implantation side and the tunnels were irrigated with 
riboflavin.
In conclusion, both visual and keratometric results after combined CXL and Fer-
rara ICRS implantation are encouraging. However, longer follow-up and larger patient 
groups are necessary. Our findings show that a combined procedure of CXL and Ferrara 
ICRS implantation is a safe treatment option in progressive moderate KC to postpone or 
avoid corneal transplantation.
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Long-term follow-up of hydrogel 
intracorneal lenses in two aphakic eyes
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IntroDuCtIon
We report the outcome of hydrogel intracorneal lens implantation in two patients. 
The lenses were implanted at approximately 50% depth in the cornea to correct high 
hyperopic refractive errors of 10.5 diopters (D) and 14.0 D, respectively. Both patients 
were contact lens intolerant and not suitable for intraocular lens (IOL) implantation. 
Surgery was performed in 1988, and the patients were followed until early 2010. The pa-
tients showed good tolerance for the intracorneal lenses, but both developed opacities 
around the implant, leading to reduced visual acuity in one patient. Long-term patient 
monitoring is essential since corneal opacities can develop after many years. Removing 
the implant is not necessary as the lens can easily be rinsed by lifting the corneal cap.
In 1966, Barraquer1 proposed synthetic intrastromal implants to alter the anterior 
corneal curvature as a way to correct refractive errors. However, his results were un-
satisfactory because of the impermeable nature of the implant material. New materials 
such as hydrogel showed biocompatibility and good corneal tolerance when implanted 
in primates.2 Hydrogel lenses are permeable to water and nutrients, so normal corneal 
physiology can be maintained. Because of its refractive index (1.376), the lens has no 
refractive power on its own within the cornea. The refractive effect is achieved by 
alteration of the corneal shape. Another advantage is that implantation is reversible. Hy-
drogel lenses were soon superseded by laser refractive surgery, and their use declined. 
However, the incidence of severe complications is higher after hyperopic laser in situ 
keratomileusis (LASIK) than after myopic LASIK.3 In this article, we report two cases of 
hydrogel intracorneal lens implantation in aphakic eyes. Both patients were considered 
unsuitable candidates for intraocular lens implantation at that time.
CaSE rEPort
Surgical technique
The hydrogel intracorneal lens is made of lidofilcon A. This material has a water content 
of 68% and is therefore permeable to glucose. A 9.0 mm corneal cap is created with a mi-
crokeratome with a 300 μm depth plate. The interface is not irrigated; excess hydration 
is removed with a sponge. The implant is placed on the stromal bed and centered on the 
nondilated pupil. The corneal cap is sutured with 16 interrupted 10-0 nylon sutures. The 
sutures are adjusted under keratoscopic control to reduce astigmatism. Postoperative 
treatment consists of antibiotic and corticosteroid eye drops.
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Case 1
A 38-year-old man experienced a penetrating injury with a foreign body through the 
cornea and lens of his left eye in 1981. The foreign body was removed through the pars 
plana, and extracapsular lens extraction with anterior vitrectomy was performed. One 
year later, surgery for a rhegmatogenous retinal detachment was performed success-
fully. The patient was contact lens intolerant. The corrected distance visual acuity (CDVA) 
was 20/25 with + 10.25 C -1.25 x 20. In 1988, a hydrogel intracorneal lens of + 10.50D 
with a diameter of 5.5 mm was implanted in the left cornea. On the second postopera-
tive day, the uncorrected distance visual acuity (UDVA) and CDVA were 20/40 and 20/20 
with + 1.0 C -1.0 x 120, respectively. Six months postoperatively, the CDVA was 20/20 
with plano C -1.50 x 25. From the first postoperative day, the cornea was clear and the 
epithelium intact. At further follow-up visits, visual acuity and keratometry remained 
stable.
Six years after implantation, reticular opacities anterior and posterior to the implant 
appeared. However, visual acuity remained stable. At 13 years, the opacities increased 
and the CDVA declined to 20/60. The corneal cap was partially reopened, and irrigation 
was performed anteriorly and posteriorly to the implant to remove the opacities. The 
corneal cap was closed without suturing. After the procedure, the cornea was clear and 
visual acuity increased to 20/20. The removed substance was analyzed. It consisted of 
amorphous crystalline structures. No classification was possible.
Over the next 9 years, visual acuity slowly declined to 20/60. Biomicroscopy showed 
recurrence of the stromal opacities. No epithelial thinning or defects were observed 
during the 22 years of follow-up. In vivo confocal microscopy (Confoscan 4, Nidek, Inc.) 
was performed 22 years postoperatively, according to a previously described method. 
Corneal backscatter analysis was calibrated using a turbidity standard (AMCO Clear, GFS 
Chemicals, Inc.). The linear relationship between turbidity and image intensity made it 
possible to convert image intensity to backscatter expressed in “scatter units.” Increased 
backscatter was seen in both interfaces and the anterior stroma (Fig 1). Total corneal 
thickness was 789 mm, including the 225 mm thick hydrogel intracorneal lens. The depth 
of implantation was 272 mm and the endothelial cell count (ECC), 1200 cells/mm2.
Case 2
A 42-year-old man was aphakic after congenital cataract extraction when he was three 
years old. Iridolenticular adhesions remained after the extracapsular extraction. He was 
contact lens intolerant. The CDVA was 20/50 (amblyopia) with + 11.50 C -2.0 x 105. In 
1988, a + 14.00 hydrogel intracorneal lens of 5.5mm diameter was implanted in the 
left cornea. On the second postoperative day, the CDVA was 20/80 with +3.0 C -1.50 x 
100. Six weeks postoperatively, it was 20/50 with and without correction (+2.0 C -0.50 
x 90). From the first postoperative day, the cornea was clear and the epithelium intact. 
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Fourteen years later, subtle corneal opacities developed anterior and posterior to the in-
tracorneal lens. The CDVA and refraction remained stable until early 2010. No epithelial 
thinning or defects were observed during the entire follow-up period. Confocal imaging 
was performed 22 years postoperatively (Fig 2).
The backscatter profile was similar to the one in Case 1, although there was more 
reflectivity in the anterior interface and subepithelial layers. The thickness of the lens 
was 225 mm, the implantation depth 385 mm, the corneal thickness 904 mm, and the 
ECC 3500 cells/mm2. Table 1 summarizes the confocal microscopy results.
DISCuSSIon
The 22-year follow-up in these 2 patients shows that intracorneal lens implantation can 
be a safe treatment option in aphakic patients. Today, Artisan (Ophtec BV) IOL implanta-
tion would be considered for the first patient. In the second patient, implantation of 
Fig. 1. Case 1: In vivo confocal microscopy performed 22 years after intracorneal hydrogel lens 
implantation.
a: The 3-dimensional stack of a complete corneal pass composed of 149 confocal images with 
approximately 6 μm intervals is shown. The intracorneal hydrogel lens (double arrow) was interspersed 
between the reflective anterior and posterior stroma - lens interfaces. b: After debridement, the anterior 
stroma - lens interface had a crackled aspect and multiple small scratches on the lens surface. C: There 
was endothelial cell loss (1200 cells/mm2) in the hydrogel lens - implanted eye. D: Four peaks could be 
identified in the backscatter profile of the hydrogel lens - implanted eye (a = endothelium; b = posterior 
interface; c = anterior interface; d = anterior stroma). E: The backscatter pattern in the fellow-eye was 
normal.
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the Artisan anterior chamber IOL would be more difficult because of the iridolenticular 
adhesions formed after the extracapsular cataract extraction. The reported explantation 
rates of intracorneal lenses range from 17% to 66%.4–6 Reasons for explantation are lens 
migration,4 lens extrusion,5 and interface deposits.7 In both our patients, intracorneal 
deposits developed more than 6 years after surgery. Years later, the opacities caused 
Fig 2. Case 2: In vivo confocal microscopy performed 22 years after intracorneal hydrogel lens 
implantation.
a: The 3-dimensional stack composed of 173 images showed pronounced backscatter of the anterior 
stroma (arrow) and the anterior interface (arrowhead). b: There was cellular debris in the posterior stroma 
- lens interface and minute scratches on the lens surface. C: The morphology of the endothelial cells in the 
hydrogel lens - implanted eye was normal. Endothelial cell density was higher than in the normal fellow 
eye (3500 versus 1270 cells/mm2). D: The backscatter profile of the hydrogel lens-implanted eye was very 
similar to that in the first case provided that the anterior interface and the subepithelial layers showed a 
higher reflectivity. E: The backscatter pattern in the fellow-eye was normal.
table 1. In vivo confocal microscopy characteristics of 2 patients 22 years after intracorneal hydrogel lens 
implantation.
mean backscatter
(Su)
Pachymetry
(µm)
ECD
(cells/mm2)
Patient 1 ICL 1631 789 1200
FE 1230 543 1800
Patient 2 ICL 1742 904 3500
FE 1295 572 1270
(ECD = endothelial cell density; ICL = eye with intracorneal lens; FE = fellow eye; SU = scatter units)
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reduced visual acuity in one patient. However, implant removal is not necessary as the 
lens can be easily rinsed by lifting the corneal cap.
The second most frequently reported complication is lens migration. In the first pa-
tient, the intracorneal lens was implanted at a depth of 278 μm and the corneal cap was 
sutured with interrupted sutures. This patient developed opacities earlier than the sec-
ond patient, with a decrease in visual acuity. More recent studies report an implantation 
depth of 120 to 180 μm.4,5 In 1990, McCarey et al.8 demonstrated that hydrogel lenses 
have to be placed between 36% and 60% of the corneal thickness for success. Deeper 
stromal implantation allows better movement of water and nutrients across the corneal 
stroma and around the edges of the alloplastic material, which might lead to fewer 
complications.9 A potential drawback of a thicker corneal cap is that the cap has to be 
sutured. McCarey et al. observed no epithelial thinning or defects, which suggests that 
the glucose metabolism is sufficient in the anterior part of the cornea after implantation 
of a hydrogel lens at this depth.
Confocal imaging has been used to evaluate short-term effects of hydrogel intracor-
neal lens implantation in animals and humans.10,11 Twenty-two years after implantation, 
both patients showed a similar backscatter profile, with increased backscatter at the 
anterior and posterior interfaces. This can be explained by a small difference in refrac-
tive index between the hydrogel lens and the surrounding stroma. Subsequent reflec-
tion at the stroma–lens interface will cause a peak in the backscatter profile, as image 
intensity is composed of backscatter and reflectance.12,13 Furthermore, deposition of 
cellular debris and crystalline structures, as we demonstrated by relifting the cap in the 
first patient, contributed to this peak formation. The peak at the anterior interface was 
higher in the second patient, possibly because irrigation and rinsing around the implant 
was done in the first patient only. Both cases also showed increased backscatter at the 
subepithelial level. This might be explained by a chronic immune response against the 
foreign material. Antigen presenting cells, which can be observed in close vicinity to the 
subbasal nerve plexus,14 could be mediators.
In conclusion, deep intracorneal lens implantation can be a safe treatment option in 
patients with high hyperopia who are contact lens intolerant and not suitable for IOL 
implantation. Long-term patient monitoring is essential because corneal opacities can 
occur after many years, with a possible reduction in visual acuity.
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GEnEraL DISCuSSIon
The first visual successful human penetrating corneal transplantation was performed by 
Eduard Zirm in 1906.1 Great advances in surgical instrumentation and techniques and 
the introduction of antibiotics and corticosteroids over the last century, significantly im-
proved the success rate of corneal transplantation. Corneal transplantation is one of the 
most widely practised forms of clinical transplantation. In the Netherlands, 995 corneal 
transplantations were performed in 2009 and 1165 in 2010.2
When to choose for a mushroom keratoplasty today?
Until recently, traditional penetrating keratoplasty (PKP) was considered the standard 
surgical method for the treatment of keratoconus (KC). However, graft rejection of the 
corneal endothelial layer is one of the most important reasons of corneal transplant 
failure.3 Deep anterior lamellar keratoplasty (DALK) leaves the unaffected endothelium 
of the patient in place, avoiding the risk of endothelial rejection. The results of the DALK 
technique are equivalent to PKP for the outcome measure of best spectacle corrected 
visual acuity, particularly if the surgical technique yields minimal residual host stromal 
thickness. Moreover, the time necessary to achieve stable results is considerably shorter 
after DALK. However, the technique is difficult, and Descemet’s membrane perforation 
remains a major complication of DALK.4 If a large perforation occurs, we have to convert 
to a full thickness graft. A mushroom shaped graft allows transplantation of a larger 
anterior diameter (9.0 mm) and leaves most of the healthy endothelium unaffected. The 
second indication for mushroom keratoplasty is a patient with deep corneal scars. The 
close proximity of the anterior layer to the limbus of the recipient may lead to suture 
loosening and wound healing problems.5 This is particularly true for allergic patients 
with vascularized corneas. To avoid this, we make a fornix-based conjunctival flap and 
place sutures into the sclera in these quadrants.
Although the corneas of our patients were steep, with an average steep keratometry-
reading of 60D and a thin periphery, our results are in line with the reported success rate 
of traditional PKP in general KC patients.6 7 Suturing a conventional full thickness graft in 
patients with a zone of marked inferior corneal thinning is more prone to a higher post-
operative astigmatism and a lower BCVA because of wound healing problems. Because 
of the particular shape of the mushroom-shaped graft, the donor and the recipient are 
locked to each other. This way, the graft is unlikely to dislocate.
Despite all the advances of posterior lamellar surgery in the treatment of corneal 
endothelial dysfunction, there are still some indications for a posterior mushroom or a 
top-hat keratoplasty. For example, a patient with endothelial dysfunction with stromal 
opacification needs a penetrating top-hat keratoplasty. A younger phakic patient with a 
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shallow anterior chamber and a pseudophakic patient with no capsule support and an 
anterior chamber lens might be other indications.
Posterior lamellar keratoplasty; how thin should it be?
Over the last few years, Descemet Stripping Automated endothelial keratoplasty 
(DSAEK) has replaced PKP as the golden standard surgical treatment for corneal endo-
thelial diseases.8 Its main advantage includes the lack of sutures, resulting in less induced 
astigmatism and a faster visual recovery. Furthermore, it is a safer technique with less 
risk for expulsive hemorrhage and suture related - complications. The main concern of 
this technique remains the rate of postoperative endothelial cell loss. 9-11 Recently, Price 
et al showed that overall graft success was comparable for DSAEK and PKP procedure.12 
However, the endothelial cell loss was higher with DSAEK at 6 and 12 months postop-
eratively, consistent with the endothelial trauma due to more donor tissue manipulation 
in DSAEK.13 Our results confirm these findings; the early postoperative endothelial cell 
loss in DSAEK is much higher (half time 2.2 months) compared to top-hat keratoplasty 
(half time 12.8 months). The opposite is true for the late endothelial cell loss; after DSAEK 
the decay of endothelial cell loss is less steep than after top-hat keratoplasty. This is 
consistent with earlier findings.14-16 In both techniques, the diagnosis of pseudophakic 
bullous keratopathy (PBK) was significant correlated with more endothelial cell loss in 
the late phase.
Recently, the thickness of the transplant layer has been further reduced. A study of 
Neff et al17 showed that a thinner endothelial keratoplasty (≤ 131 µm) is correlated with 
a higher postoperative visual acuity compared to thicker transplants (> 131 µm). How-
ever, donor preparation, positioning, and attachment are more challenging with thinner 
transplant tissue, resulting in more donor tissue loss and a higher re-bubbling rate.18 
Future innovation might come of a hybrid technique that combines the visual result of 
DMEK and the stability of a DSAEK graft.19
Combined treatment options with corneal cross-linking
UV-A induced corneal cross-linking (CXL) has been shown effective in progressive KC; a 
decrease in maximal keratometry readings of 2 to 3 D and an increase in UCVA of 1 or 
2 lines.20-22 However, other treatment methods for KC (e.g., intracorneal ring segments) 
yield more significant improvement in visual acuity and keratometry.
In order to obtain both the stabilizing effect of CXL and the visual benefit of intracor-
neal ring segments on corneal ectasia, these two treatment procedures can be com-
bined. Reported results in KC patients showed an average improvement in UCVA and 
BCVA of two lines, a significant decrease in spherical equivalent of 2 D and a decrease 
in maximum K value of 2 to 4 D.23-25 Our results are more favorable; an increase in UCVA 
and BSCVA of 5 and 3 lines, respectively. Mean keratometry and spherical equivalent 
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decreased with 3 and 3.5 D, respectively. El-Raggal confirmed in his comparative study 
that a significant greater topographic improvement is obtained when ring segment 
insertion and CXL are performed in one session compared to two sessions. No sig-
nificant differences were found in visual acuity outcome.26 The second treatment option 
to obtain both structural and refractive improvement is the combination of CXL with 
topography-guided photorefractive keratectomy (PRK).27 However, long term outcome 
is yet unknown. Finally, the residual refractive error after CXL can be corrected by a toric 
intraocular (phakic) lens. 28
Intracorneal lenses; what is in for the future?
In 1966, Barraquer proposed synthetic intrastromal implants to alter the anterior corneal 
curvature to correct refractive errors.29 However, his results were unsatisfactory because 
of the impermeable nature of the implant material. New materials such as hydrogel 
showed biocompatibility and good corneal tolerance when implanted in primates.30 
Because of its refractive index (1.376), the lens has no refractive power on its own within 
the cornea. The refractive effect is achieved by alteration of the corneal shape. Hydrogel 
lenses were soon superseded by laser refractive surgery, and their use declined.
Today, Artisan (Ophtec, BV) lens implantation would be considered in our patient 
(case 1) with posttraumatic aphakia. In the second patient, an Artisan anterior chamber 
lens implantation would be more difficult due to the iridolenticular adhesions formed 
after the extracapsular lens extraction.
Recent studies on intracorneal lenses report a high explantation rate (range from 17% 
to 66%).31,32 Reasons for explantation are lens migration31, lens extrusion32 and interface 
deposits.33 The implantation depth in these studies measured 120 – 180 µm.31-33 In 1990, 
McCarey demonstrated that hydrogel lenses need to be placed deeper in the corneal 
stroma, at a depth between 36% and 60% of the corneal thickness, for success.34 In our 
two patients, the depth of implantation was 272 µm and 385 µm, respectively. During 
follow-up, no lens migration or extrusion was seen.
In our two patients, intracorneal deposits developed more than 6 years after surgery. 
Years later the opacities caused reduced visual acuity in one patient. We showed that 
implant removal is not necessary, since rinsing of the lens can easily be done by lifting 
the corneal cap.
Recently, interest in intracorneal implants has resurfaced, especially for the correction 
of presbyopia.35,36 The requirements for future intracorneal implants will be: thin, small 
diameter, high nutrient and fluid permeability, and implantation relatively deep in the 
stroma.37,38
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SummarY
In the General Introduction, an overview of all types of corneal transplantations 
with their indications and results are presented. Secondly, a review of the literature of 
published studies on intracorneal ring segments (ICRS), intracorneal lenses and corneal 
cross-linking (CXL) is given.
In Chapter 1 we describe the clinical outcome of posterior mushroom or top-hat kerato-
plasty in 22 eyes with Fuchs endothelial dystrophy and pseudophakic bullous keratopathy. 
One year after surgery, good visual acuity and keratometric results were obtained in our 
study group. During follow-up, these results remained stable. Postoperative endothelial 
cell loss was in line with reported results on traditional penetrating keratoplasty (PKP).
Chapter 2 analyzes the visual and keratometric results of mushroom keratoplasty in 15 
patients (16 eyes) with advanced keratoconus (KC). Although our patients all had ad-
vanced KC, with an average keratometry reading of 58 diopters (D) and a thin periphery, 
visual results were comparable with the outcome of standard PKP in general KC patients. 
The relatively good postoperative visual acuity might be explained not only by the low 
extent of astigmatism, but also by the greater surface regularity owing to the larger 
anterior diameter.
In Chapter 3 we evaluate the endothelial cell loss after both mushroom keratoplasty and 
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) using biexponential 
endothelial regression models. The models show that early postoperative endothelial 
cell loss in DSAEK is much higher (half time 2.2 months) compared to mushroom kera-
toplasty (half time 12.8 months). This finding is in line with previous reported results, 
and is consistent with the endothelial trauma due to more donor tissue manipulation in 
DSAEK. The opposite is true for the late endothelial cell loss; after DSAEK the decay of en-
dothelial cell loss is less steep than after mushroom keratoplasty. This is consistent with 
earlier findings. In both techniques, the diagnosis of PBK was significantly correlated 
with more endothelial cell loss in the late phase.
In Chapter 4 we describe a case of immunological graft rejection with an endothelial 
rejection line (Khodadoust line) four months after DSAEK. Contrary to our instructions, 
the patient had stopped using the steroid eye drops one month postoperatively and she 
did not visit her own ophthalmologist. Previously, it was generally assumed that endo-
thelial rejection lines did not occur after DSAEK procedure due to the absence of graft 
vascularization. Our case illustrates that an endothelial rejection line can be observed 
after DSAEK, independent of graft vascularization.
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In Chapter 5 we report a case of introduction of epithelial cells in the flap-graft interface 
during DSAEK. A 67-year-old woman underwent DSAEK procedure of the left eye be-
cause of visual limiting bullous keratopathy. A cornea from a male donor was used. One 
week postoperatively, the donor lamella was partially detached and an additional air 
bubble was injected. Four months postoperatively, the donor lamella was attached, but 
the interface was slightly hazy. One year after DSAEK, total corneal decompensation was 
seen, and a posterior mushroom keratoplasty was performed. Histopathologic examina-
tion of the removed corneal button showed two cysts, lined with squamous epithelium, 
at the interface. The X-Y karyotyping revealed that the epithelial cells were of donor 
origin. We postulate that the donor epithelium was implanted during the preparation 
of the donor posterior lamellar disc and was introduced intraoperatively. If complete 
attachment of the donor posterior lamella is accomplished, ectopic epithelial cells in 
the interface might remain stable without proliferation. In a partially detached donor 
lamella, ectopic epithelial cells might proliferate along the recipient’s posterior cornea.
Our findings in Chapter 6 show that a combined procedure of Ferrara ICRS implantation 
and CXL is a safe treatment option in progressive moderate KC in order to postpone or 
avoid corneal transplantation. We included 7 eyes (7 patients) with progressive KC with 
a clear cornea, contact lens intolerance and an average keratometry of less than 53 D. 
Patients with a corneal thickness of less than 400 μm and a mesopic pupil diameter 
more than 5.5 mm were excluded. After one year, uncorrected visual acuity and best 
spectacle-corrected visual acuity increased with 5 and 3 lines, respectively. Mean kera-
tometry and spherical equivalent decreased with 3 D and 3.5 D, respectively.
In Chapter 7 we report the outcome of hydrogel intracorneal lens implantation in two 
aphakic patients. The lenses were implanted at approximately 50% depth in the cor-
nea to correct high hyperopic refractive errors of 10.5 D and 14.0 D, respectively. Both 
patients were contact lens intolerant. At the time, both patients were considered unsuit-
able candidates for an intraocular lens. Surgery was performed in 1988, and the patients 
were followed until early 2010. The patients showed good tolerance for the intracorneal 
lenses, but both developed opacities around the implant, leading to reduced visual acu-
ity in one patient. Removing the implant is not necessary as the opacities around the 
lens can easily be rinsed by lifting the corneal cap.
Isabelle BW.indd   122 09-Sep-11   12:23:16 PM
Summary / Samenvatting 123
SamEnvattInG
De Inleiding geeft een overzicht van alle types van hoornvliestransplantaties met bijho-
rende indicatiegebieden en resultaten. Tevens wordt er een literatuuroverzicht gegeven 
van verschillende recente studies over de resultaten na intracorneale ringsegmenten, 
intracorneale contactlenzen en corneale crosslinking.
In Hoofdstuk 1 evalueren we de klinische resultaten van een posterieure mushroom 
keratoplastiek die werd uitgevoerd in 22 ogen met Fuchs’ endotheeldystrofie en pseu-
dofake bulleuze keratopathie. Eén jaar na de ingreep hadden de patiënten een goede 
gezichtsscherpte en goede keratometrie waarden. Tijdens de follow-up periode bleven 
deze beide parameters stabiel. Het postoperatief verlies aan endotheelcellen was verge-
lijkbaar met het verlies na een conventionele perforerende keratoplastiek (PKP).
Hoofdstuk 2 analyseert de gezichtsscherpte en keratometrie waarden bij 15 patiën-
ten (16 ogen) met vergevorderde keratoconus (KC) die een mushroom keratoplastiek 
ondergingen. Al onze patiënten hadden een vergevorderd stadium van KC, met een 
gemiddelde keratometrie waarde van 58 dioptrie (D) en een dun perifeer hoornvlies. 
Toch zijn de resultaten vergelijkbaar met patiënten die een matig steile KC hadden 
en daarvoor een conventionele PKP ondergingen. Er was postoperatief weinig astig-
matisme. Dit verklaart de relatief goede gezichtsscherpte postoperatief. Ook geeft de 
grotere voorste diameter van het transplantaat een meer regelmatig oppervlak, wat de 
gezichtsscherpte positief beïnvloedt.
In Hoofdstuk 3 evalueren we het endotheelcelverlies na een mushroom keratoplastiek en 
een posterieur lamellaire keratoplastiek (DSAEK: Descemet Stripping Automated Endothe-
lial Keratoplasty) met behulp van biexponentiële regressiemodellen. Deze laten zien dat 
het vroegtijdig endotheelcelverlies na DSAEK veel hoger is (halfwaardetijd 2.2 maanden) 
dan na een mushroom keratoplastiek (halfwaardetijd 12.8 maanden). Deze bevinding is in 
lijn met voorgaande publicaties. Endotheelschade veroorzaakt door meer donorweefsel 
manipulatie bij DSAEK wordt als de meest logische verklaring hiervoor beschouwd. Het 
omgekeerde is waar voor het laattijdig endotheelcelverlies; bij DSAEK is dit endotheelcel-
verval minder groot. De diagnose pseudofake bulleuze keratopathie is bij beide vormen 
van hoornvliestransplantatie gecorreleerd met een groter laattijdig endotheelcelverlies.
In Hoofdstuk 4 beschrijven we een immunologische afstotingsepisode met een en-
dotheliale rejectielijn (Khodadoustlijn) na DSAEK. De patiënte was, op eigen initiatief, 
een maand na de ingreep gestopt met de steroïd druppels. Ook ging zij niet langer op 
controle bij haar eigen oogarts. Voorheen werd aangenomen dat een Khodadoustlijn 
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niet kan voorkomen bij DSAEK vanwege de afwezige vaatingroei in het transplantaat. 
Onze casus toont aan dat er wel degelijk een Khodadoustlijn kan voorkomen na DSAEK, 
onafhankelijk van de vaatingroei.
In Hoofdstuk 5 rapporteren we de aanwezigheid van donor epitheelcellen in de inter-
face na DSAEK. Een 67-jarige vrouw met bulleuze keratopathie onderging een DSAEK. 
Het hoornvlies was afkomstig van een mannelijke donor. Een week na de ingreep werd 
er een extra luchtbel in de voorste oogkamer ingebracht omdat de donor lamel niet vol-
ledig aanlag. Vier maanden postoperatief werden er lichte troebelingen in de interface 
gezien. Een jaar na de ingreep was er sprake van een volledige decompensatie van het 
hoornvlies waarvoor een posterieure mushroom keratoplastiek moest worden verricht. 
Pathologisch onderzoek van het verwijderde hoornvlies laat ter hoogte van de interface 
twee epitheelcysten zien. X-Y karyotypering toont aan dat de epitheelcysten afkomstig 
zijn van de mannelijke donor. Wij gaan ervan uit dat de donor epitheelcellen zijn inge-
bracht samen met de donorlamel. Als de lamel volledig aanligt, blijven deze ectopische 
epitheelcellen waarschijnlijk stabiel zonder proliferatie. Indien de donor lamel niet vol-
ledig aanligt, kunnen deze epitheelcellen vrij proliferen ter hoogte van de interface, met 
mogelijk falen van het transplantaat tot gevolg.
De veiligheid en doeltreffendheid van een gecombineerde behandeling met Ferrara 
intracorneale ringsegmenten en crosslinking bij progressieve KC worden besproken 
in Hoofdstuk 6. Wij behandelden 7 patiënten met progressieve KC met een heldere 
cornea, contactlens intolerantie en een gemiddelde keratometrie waarde van 53 D of 
minder. Patiënten met een corneale dikte van minder dan 400 μm en een mesopische 
pupildiameter van meer dan 5.5 mm werden uitgesloten. Eén jaar na de ingreep waren 
de ongecorrigeerde en gecorrigeerde gezichtsscherpte (met bril) toegenomen met res-
pectievelijk 5 en 3 lijnen. De gemiddelde keratometrie waarde en het sferisch equivalent 
waren met respectievelijk 3 D en 3.5 D afgenomen.
In Hoofdstuk 7 beschrijven we twee patiënten waarbij een hydrogel lens in de cornea 
werd geïmplanteerd ter correctie van hun hoge hypermetropie (10.5D en 14D). De lens 
werd geplaatst op ongeveer 50% diepte in het hoornvlies. Beide patiënten waren afaak 
en contactlens intolerant. Ze werden toen ongeschikt bevonden voor intraoculaire 
lensimplantatie. De operatie vond plaats in 1988 en de patiënten werden opgevolgd tot 
in 2010. Beide patiënten hebben een goede tolerantie voor de intracorneale lens, maar 
ontwikkelden beiden opaciteiten rond het implantaat. De opaciteiten zorgden bij één 
patiënt voor een vermindering van de gezichtsscherpte. Verwijderen van de intracor-
neale lens was niet nodig. De opaciteiten rondom de lens kunnen weggespoeld worden 
door de corneaflap te liften.
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GEnEraL IntroDuCtIon
Fig 1. Corneal structure. (J Leenen)
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CHaPtEr 1
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Fig 1. The trephination technique of the donor cornea. (J Leenen)
A-B: The geometric centre of the donor cornea is marked and the Barron suction trephine (7.5 mm in 
diameter) is used to make a circular incision of 0.3 mm depth.
C-D: A lamellar stromal dissection was carried out from the base of the incision to the limbus.
E-F: The cornea was removed from the artificial anterior chamber and placed on a Barron suction punch 
(Katena) with the endothelial side up. A 9.0-mm donor button was punched out.
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Fig 2. The trephination technique of the recipient cornea. (J Leenen)
A: The geometric centre of the recipient cornea is marked and the Barron suction trephine (7.5 mm in 
diameter) is used to make a circular incision of 0.3 mm depth.
B: The cornea was marked with a 9 mm trephine and a lamellar stromal dissection was carried out from 
the incision to the 9.0 mm mark.
C: The anterior chamber was entered, and corneal scissors were used to complete the excision of the 
corneal button at the peripheral end of the posterior lamellar stromal dissection.
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CHaPtEr 2
Fig 1. Trephination technique of donor cornea. 
(J Leenen)
A, The Barron suction trephine (9.0 mm in diameter) is 
used to make a circular incision of 0.3-mm depth.
B, A lamellar stromal dissection was carried out from 
the circular incision up to the 7.0-mm mark.
C, The donor cornea with a larger anterior stromal 
lamella (9.0 mm in diameter) and a smaller posterior 
part (7.0 mm in diameter)
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Fig 2. Trephination technique of recipient cornea. (J Leenen)
A, The geometric center of the recipient cornea is marked. The Barron suction trephine (9.0 mm in 
diameter) is used to make a circular incision of 0.3-mm depth.
B, A lamellar stromal dissection was carried out from the circular incision up to the central 6.5-mm mark.
C, Vannas corneal scissors were used tocomplete the excision of the corneal button.
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Fi g 3. Keratoplasty in a recipient cornea with a thin periphery. (J Leenen)
A, Problematic wound healing of a normal thickness donor cornea to a 1-sided thin recipient in 
conventional keratoplasty with a vertical cut.
B, Mushroom graft to a 1-sided thin recipient; no dislocation occurs.
CHaPtEr 4
Fi g. 1. Khodadoust line (J Leenen)
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CHaPtEr 5
Fig 1. There are two cysts at the interface between the recipient cornea and the posterior endothelial 
graft tissue (A), and the lining of the cysts stains strongly positive for the epithelial markers 34Be12 and 
keratin 5/6 (B).
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Fig 2. In situ hybridization with X and Y chromosome probes revealed 2 X chromosomes (arrow) in the 
epithelium and the stroma of the recipient (A) and 1 X chromosome (arrow) in the epithelium of the cyst 
(B). C, The epithelium of the cyst wall contained 1 Y chromosome (arrows). D, There was no staining of the 
Y chromosome probe (arrow) in the tissue of the recipient.
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